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INTRODUCTION 
 
Glaucoma is a term referring to a group of complex diseases, which 
damage the optic nerve head and retinal ganglion cells, leading to progressive, 
irreversible vision loss. Glaucoma is the second leading cause of blindness 
worldwide (1).  
Glaucoma as a disease has been known to the medical world since time 
immemorial. In modern medicine, its discovery dates back to the 17th century. 
Hippocrates described a disease condition he called as ‘Glaykoseis’, which 
caused blindness in the old, associated with a glazed appearance of the pupil. (2) 
The word glaucoma is derived from ancient Greek, meaning ‘clouded or 
blue-green hue’, probably due to the description of a person with a swollen 
cornea or who was rapidly developing a cataract, both of which may be caused 
by chronic elevated pressure inside the eye (cataracts and glaucoma not 
distinguished until c.1705). The definition of glaucoma has changed 
dramatically from the time of its inception in 400 BC. The first documentation 
of glaucoma was in the Arabian writings, “Book of Hippocratic treatment”, of 
At-Tabari (10th century). (2) 
Richard Banister, an English ophthalmologist (1622), was the first person 
to establish a relationship between increased intraocular pressure and optic nerve 
head damage and described it as a disease entity consisting of four features; eye 
tension, long duration of the disease, the absence of perception of light and the 
presence of a fixed pupil (2) 
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In the early 19th century, the first modern description of the disease, and 
its relation to raised intraocular pressure, was given by Antoine-Pierre Demours 
(1818). Thereafter, the central concept of a rise in the intraocular pressure being 
a cause for the changes, became fully established. G.J. Guthrie (1823), in 
London, established hardness of the eye as characteristic of a disease, which he 
called Glaucoma. Ultimately, the essential feature of raised intraocular tension 
was fully established by William McKenzie, the Scottish clinician (1835) who, 
in his textbook, described the raised tension in both chronic and acute glaucoma.  
Another seminal clinical observation in this period was the uniting 
concept of Donders (1862) where he described a debilitating increased 
intraocular tension occurring without any inflammatory symptoms as Simple 
Glaucoma. Drance (1973), for the first time, provided the definition of glaucoma 
as a disease of the optic nerve (an optic neuropathy), which is caused by a 
number of factors. 
Further advancement in the diagnosis of glaucoma was achieved by the 
invention of the tonometer, the perimeter and more recently, optical coherence 
tomography. These tests provide a clinical measurement of integrity of the 
structure and function of the neural elements damaged in glaucoma, i.e., the 
retinal ganglion cells and their axons.  
Today, despite these advancements, according to the World Health 
Organization, 55 million people are affected worldwide by Glaucoma (Resnikoff). 
Twelve million persons worldwide are estimated to be blind because of the 
disease. It is a disease, which strikes without any warning signs. The visual 
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impairment is so gradual that the patient may not notice a change in vision until 
the condition is at an advanced stage and diagnosis is frequently delayed. If 
glaucoma can be diagnosed early, further vision loss can be slowed or prevented. 
However, the biological basis of glaucoma is poorly understood and many 
diagnostic and therapeutic challenges remain. (3) One of the proposed causes for 
the retinal damage in glaucoma is change in the blood supply and vasculature, at a 
microscopic level. A vascular etiology for glaucoma has been suspected for many 
decades. Several investigative modalities have been used to assess the blood flow 
at the optic disc and peri-papillary retina, in glaucoma patients. But, a gold 
standard test that provides all the necessary information in one reading has yet to 
be established to quantify the features of the micro-vascular network.  
       Optical coherence tomography (OCT) is a relatively new, non-invasive 
modality in ocular imaging. Using light instead of ultrasound, it provides high-
resolution cross sectional images of the optic nerve head, retina and deeper 
structures. An even more recent advance, derived from OCT is Optical 
Coherence Tomography Angiography (OCTA) which is helping us study retinal 
blood flow using the principle of studying de-correlation between the signals of 
OCT cross-sectional scans repeated at the same location, caused by blood flow, 
thus providing a detailed view of the vascular structures in the retina and optic 
nerve head.  This technology has the advantage of being noninvasive, rapid and 
reproducible.   
Using OCTA (DRI-TRITON Plus), in our study, we analyze and compare 
the vascular density in the optic disc, papillary and peri-papillary areas in normal 
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eyes, glaucoma suspects (Ocular hypertensives) and in diagnosed early glaucoma 
patients. This investigation modality, though widely used to study retinal 
microcirculation, has not been extensively studied for its effectiveness in the 
diagnosis and prognostication of glaucoma, in the Indian population. 
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AIM 
To analyze retinal vascular density using swept source optical coherence 
tomography angiography (OCTA) in patients with early primary open angle 
glaucoma (POAG), Glaucoma suspects (Ocular Hypertensives), and normal eyes. 
 
 
OBJECTIVES 
1. To analyze and compare Vascular density index in the optic disc, papillary 
area and peri-papillary area, using OCTA, in Normals, Glaucoma suspects 
(Ocular Hypertensives) and diagnosed early POAG patients. 
 
2. To investigate the correlation between retinal vessel density measurements 
and other parameters like retinal nerve fiber layer thickness and visual 
field changes (mean deviation) on automated perimetry. 
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REVIEW OF LITERATURE 
 
Glaucoma is a chronic, progressive optic neuropathy caused by a group of ocular 
conditions, which lead to damage of the optic nerve with characteristic changes 
of the optic nerve head, and corresponding visual field defects, (4) with 
intraocular pressure (IOP) the only modifiable risk factor and IOP reduction the 
only treatment. The nerve damage results from loss of retinal ganglion cells 
(RGC) (5-8) 
Types of glaucoma 
 
Colour Plate 1: Open angle type (left) and closed angle type (left) 
 
Colour Plate 2: The glaucoma continuum (9) 
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Disease burden 
 Glaucoma is the second leading cause of blindness worldwide. Twelve 
million persons worldwide are estimated to be blind because of the disease. (4) 
With the exception of Asia, Primary open angle glaucoma (POAG) is far more 
common than Primary angle-closure glaucoma (PACG), accounting for around 
three fourth of all glaucoma cases worldwide. (10) In Asia, population-based 
studies from China and India have reported that a significant percentage of the 
population suffers from angle-closure glaucoma. (11-16).  
More importantly it is the most common cause of irreversible blindness in the 
world and it is estimated that more than 3 million people are blind due to this 
disease. (17) 
 
The estimated prevalence of the disease in the word was 60.5 million in 
2010, and is expected to rise to 79.6 million by 2020 (10) Several population 
based studies have been conducted to throw light on the prevalence of glaucoma 
in India, important among them are: - 
1. Vellore Eye Study (VES) 
2. Chennai Glaucoma Study (CGS) 
3. Andhra Pradesh Eye Disease Study (APEDS) 
4. West Bengal Glaucoma Study (WBGS) 
5. Aravind Comprehensive Eye Survey (ACES)  
 
9	
	
 
 Table 1: Summary of different population based studies from India (68) 
 
 
Table 2: Age Standardized Rates for POAG and PACG for the Population Aged Above 40 y 
(Standardized to the Population of India 2008 Population Estimates) (68) 
 
 
Table 3: Age Wise Prevalence of Primary Open Angle Glaucoma in Different Studies (68) 
 
 
In India, the disease burden due to glaucoma is severe, accounting for 
about one fifth of the global burden. Even though two third of all glaucoma 
cases in Caucasians are primary open angle glaucomas, studies show that the 
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Indian population has an equal proportion of open and close angle glaucomas. 
(10)  
 The prevalence of POAG in south India, among the rural population, 
aged 40 and above, was 1.7% according to the AECS. (18) This was in contrast 
to the observations in the urban south Indian population, which showed a 
prevalence of 3.5% in the Chennai Glaucoma Study. (19). A more alarming fact 
discovered in these surveys, was that greater than 90% of the glaucoma cases 
were lying undiagnosed and were identified only during the surveys (93% in 
ACES and 98.6% in the Chennai Glaucoma Study). The National Blindness 
survey, conducted in 2001, showed that glaucoma is the third major cause of 
irreversible blindness in India and responsible for 5.9% of blindness (i.e., visual 
acuity of <6/60) (20). The recent surveys have shown a threefold increment in 
blindness due to glaucoma as found in previous surveys and literature (21) 
 
Despite all this, we are of the opinion that blindness due to glaucoma is 
grossly underestimated as most of these surveys have defined blindness based on 
visual acuity alone and have not given equal importance to visual fields, which 
form one of the defining criteria for glaucoma. Hence in order to identify more 
cases correctly, we need to start from understanding the anatomy, physiology of 
the optic nerve head and retinal ganglion cells, their blood supply, pathogenesis 
and progression of glaucoma as a disease. The understanding of the above will 
aid in correlating the findings in the investigation being studied. 
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Aqueous secretion and outflow (22) 
Aqueous humour is produced, from the ciliary processes, in two steps, 
i.e., formation of a plasma filtrate within the stroma of the ciliary body and 
formation of aqueous from this filtrate across the blood-aqueous barrier.  
This occurs by active and passive processes. 
 
  The aqueous outflow occurs from the posterior chamber via the pupil 
into the anterior chamber, to the angle of the anterior chamber. From here, 
the exit occurs, in its most part, through the sieve-like trabecular meshwork, 
at the angle of the anterior chamber (consisting of the uveal, corneoscleral 
and juxtacanalicular meshworks), and the Schlemm canal (Trabecular or 
conventional outflow 90%) and partly through the Uveoscleral route (10%).  
 
Intraocular pressure (23) 
The intraocular pressure is decided by the balance between the rate of 
aqueous production and outflow. The latter is in turn determined by the 
resistance encountered in the outflow channels and to the level of episcleral 
venous pressure. 
The distribution of IOP within the general population falls within the range 
of 11–21 mmHg. Although there is no definite pathological cutoff point, 21 
mmHg is considered the upper limit of normal and levels above this warrant 
investigation. However, in some patients glaucomatous damage occurs with 
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IOPs less than 21 mmHg (normal-tension glaucoma) whilst others remain 
unaffected with IOPs as high as 30 mmHg (ocular hypertension). Although the 
actual level of IOP is a cornerstone in the development of glaucomatous 
damage, other factors are also significant. There can also be variations in IOP 
with time of day, blood pressure, respiration, valsalva etc. A diurnal variation of 
up to 5 mm hg may be seen in normal eyes, and fluctuations greater than this 
are suspicious of glaucoma. 
 
Normal optic nerve head (24) 
The optic nerve head (ONH) or the optic disc consists of the neuroretinal 
rim and the optic cup. The neuroretinal rim (NRR) is the rim of tissue between 
the optic disc margin and the outer edge of the optic cup. It is normally 
described as pink or orange in colour with the inferior rim being the broadest. 
The optic cup is the central depression seen within the confines of the NRR. 
The normal size of the cup is largely determined by the size of the disc itself, 
the smaller discs having smaller cup sizes and vice versa. 
The ONH can be divided into four cross-sectional parts: the surface layer 
and the prelaminar, laminar, and retrolaminar portions, each with its own blood 
supply and glial tissue. 
The arrangement of the axons of the retinal ganglion cells from the 
peripheral retina toward the optic nerve is such that axons from peripheral 
ganglion cells are progressively over-layered by axons derived from cell bodies 
closer to the optic nerve. These peripheral fibers remain peripheral as they enter 
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the disc; central fibers enter centrally, lying closer to the physiological cup. This 
arrangement is responsible for the manner of clinical progression of the 
glaucomatous field defect; i.e., paracentral scotomas appear early. 
 
Colour Plate 3: Schematic diagram of the axonal arrangement at optic nerve 
head (33) 
 
Blood Supply (25-32) 
The central retinal artery (CRA) and the short posterior ciliary arteries 
(SPCAs), together form a capillary plexus that supplies the ONH. The venous 
drainage of the ONH is almost entirely through branches of the central retinal 
vein, although important choroidal collaterals exist, which open up in case of 
any disturbance to the normal channels. 
The surface layer of the ONH is supplied by the central retinal artery 
(responsible for flame shaped haemorrhages seen clinically); prelamiinar part is 
supplied by branches from the short posterior ciliary arteries. Most studies 
believe that vessels derived from the peripapillary choroid make only a minor 
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contribution to the blood supply of the anterior ONH. The laminar portion is 
supplied by centripetal SPCAs, and also a longitudinal anastomotic capillary 
bed. The anterior portion of the retrolaminar nerve has both, centripetal 
branches from the pia-meninges, and also branches from the central retinal 
artery. 
 
 
Colour Plate 4: Composite illustration of the various optic nerve vascular 
arrangements (25) 
 
The pathogenesis of glaucomatous damage is attributed to a combination of 
factors affecting axonal health, with each factor being interlinked in its effects to 
all the others. 
The two main influences are: 
• Mechanical changes due to the rise of intraocular pressure 
• Vascular perfusion of the optic nerve head. 
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GLAUCOMA: A Vascular Dysregulation 
  The Optic nerve head and RNFL is largely comprised of the axons 
of RGCs, one of the most metabolically active cells in human body. These cells 
have tremendous metabolic requirements and depend on regional capillary 
networks to meet them. 
 
  Several studies have reported that vascular factors may play a 
critical role in the development of glaucoma in addition to elevated IOP (6-8, 34, 
35) and have demonstrated reduced ocular blood flow in optic nerve head and 
retinal circulation in glaucoma. (36-47) 
 
  The perfusion of the optic nerve head may be affected because of a 
lack of an adequate auto regulatory mechanism. A substantial rise in intraocular 
pressure can also decrease the capillary blood flow due to mechanical 
compression of vessels at the lamina cribrosa or a decreased flow in the annulus 
of Zinn, which supplies nutrition to the laminar and post-laminar optic nerve 
head. A fall in perfusion pressure at the optic disc may additionally be caused by 
systemic factors such as hypotension, vasospasm and acute blood loss. (4) 
 
Generalized narrowing of the retinal vessels has been found in cases with 
advanced glaucomatous damage. Before the availability of semi-automated 
machines, retinal vessel calibers in glaucoma patients were measured via 
manual means. (41, 46, 48) 
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The reduction in caliber was seen more in arteries than in veins, with 
areas of greater ONH damage and thinner retinal nerve fibers, showing reduced 
caliber.  An attempt is made to explain this association between area of ONH 
damage and reduction in vessel caliber: - 
 
One opinion is that, Retinal ganglion cell loss has been suggested to 
result in vasoconstriction as an adjustment to reduced metabolic demand. This is 
in agreement with the observation of retinal arterial narrowing in patients with 
non-glaucomatous optic atrophy. (62–64)  
 
Alternatively, the other opinion is that, the underlying pathological 
process leading to RGC loss is related to impaired local auto regulation, 
vasoactive substance leakage and consequently vasoconstriction. (46, 49, 50, 
51). 
 
Population based studies have also further seconded the above findings. 
The Blue Mountains Eye Study (BMES) showed that patients with POAG were 
2.7 times more likely to show generalized retinal arteriolar narrowing than 
patients without glaucoma. This remained true after adjusting for risk factors for 
glaucoma and is independent of ocular perfusion pressure. (52). The Singapore 
Malay Eye Study found consistently, a relationship between quantitatively 
measured retinal vascular caliber and prevalence of glaucoma and larger 
17	
	
vertical cup–disc ratio (CDR) (53). Yoo et al reported similar findings of retinal 
arteriolar narrowing in glaucomatous eyes, and further found that thinning of 
retinal arteriolar caliber was comparable to thinning of retinal nerve fiber layer 
in detecting open angle glaucoma (54). 
 
Thus, population-based and hospital-based cross-sectional studies have 
largely supported the association between narrowing of retinal vessel caliber 
and glaucoma. 
Several non-invasive and invasive techniques have been developed to 
study optic nerve head and peri-papillary retinal blood flow. 
Noninvasive techniques 
• Color Doppler imaging (CDI), 
• Laser Doppler Velocimetry (LDV) 
• Laser speckle technique 
• Laser Doppler Flowmetry (LDF) 
• Retinal vessel analyzer (RVA) 
• Retinal oximetry 
• Blue field entoptic technique. 
Invasive techniques 
• Scanning laser ophthalmoscopy angiography with fluorescein and/or 
Indocyanine green (ICG) dye. 
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 Most of the studies using available technologies demonstrated reduced 
blood supply in the optic nerve and peri-papillary retina of glaucoma patients and 
some confirmed a correlation between severity of the disease and the degree of 
hemodynamic disturbance. (34, 55-58) 
 
 Despite the critical role of the capillary plexus in the optic nerve head and 
RNFL changes, leading to glaucomatous damage, suggested by several 
investigators, our previous inability to quantify micro vascular network density 
features, and the lack of a reproducible and relevant in vivo quantitative 
assessment method, has prevented evaluation of the clinical characteristics of the 
capillary beds, at a microscopic level and obtaining a more comprehensive 
understanding of the RGC axonal damage in glaucoma. 
 
 A reliable clinical method for imaging these vascular beds would improve 
our knowledge about the role of capillary vascular plexus in RGC axonal health 
and disease. (59) 
 
 Functional changes, as assessed by automated perimetry or visual field 
testing, occur only after 40% of RGC loss, which is quite late. Hence methods to 
detect any insults occurring early on in glaucoma, before functional/ field 
changes develop are important. 
 
 Also, better understanding of the vascular changes in patients with 
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glaucoma, can give rise to other management options, especially in patients who 
show progressive glaucomatous damage despite adequate lowering of IOP. 
 
 Fluorescein angiography can provide useful information about the 
vasculature of the optic disc, but this is an invasive test with its own 
complications and also, the information obtained is limited to the larger vessels 
only. A high-resolution image of the papillary and peri-papillary 
microvasculature cannot be practically obtained. Spaide et al (60) obtained 
spectral domain OCT Angiography images from the ONH of 12 healthy subjects 
and compared the peri-papillary capillary network with images obtained by 
fluorescein angiography. They reported that the radial peri-papillary capillary 
network could not be visualized by fluorescein angiography, whereas the network 
was readily visualized in OCT Angiography images. 
 
Optical Coherence Tomography (OCT) 
 
 Optical coherence tomography (OCT) is a non-invasive, non-contact 
imaging system, which provides high-resolution cross-sectional images of the 
retina, vitreous, and optic nerve head. 
 
 OCT technology uses low-coherence interferometry to capture high-
resolution cross-sectional images of tissue morphology, providing images to 
derive an optical biopsy section. It is analogous to ultrasound except it uses 
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light instead of sound. Low-coherence near-infrared light is produced by a 
diode light source, and transmitted to the retina via a fiber optic delivery 
system. The backscattered rays from the retina are captured and utilized to 
construct a cross-sectional tomographic image of the retinal area analyzed. It 
permits a dynamic, real time imaging of retina and its pathology, and also 
provides quantitative information about retinal architecture at high resolution. 
(61)  
 
 The following imaging strategies are applicable to glaucoma: 
1. Peri-papillary retinal nerve fiber layer. This involves the acquisition of a 
circular scan of diameter 3.4 mm of the retina around the optic nerve head. 
Retinal thickness is compared with normals. Sensitivity and specificity are 
around 90%. 
2. Optic nerve head. Radial cross-sectional scans permit an objective and 
repeatable assessment of disc morphology, with reasonable discriminatory 
value. This function has tended to be less commonly used than RNFL analysis 
in practice. 
 
 OCT gives an objective measurement of retinal nerve fiber layer (RNFL) 
thickness and/or ganglion cell complex (GCC), which is important for 
glaucoma assessment.  The commercially available spectral domain (SD)-OCT 
offers benefits in glaucoma assessment over the earlier generation of time 
domain-OCT due to increased axial resolution, faster scanning speeds and has 
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been reported to have improved reproducibility but similar diagnostic accuracy. 
Newer advances in OCT technology have enabled increases in scanning speed 
to 20,000– 50,000 A-scans/second and even up to 100,000 A-scans/second, to 
produce of a truly three dimensional image of the site of interest with 
reproducible registration, and advanced segmentation algorithms of macular and 
optic nerve head regions. It allows visualization of the individual retinal layers, 
comparable to a conventional histopathology section. But it has limited utility in 
advanced disease and does not relate to cause of disease as opposed to the final 
presentation. (62) 
 
Optical Coherence Tomography Angiography (OCTA) In Glaucoma 
Optical coherence tomography angiography is an emerging technology, 
with the potential to lead to a paradigm shift in glaucoma diagnostics. 
 
 OCTA is a new, non-invasive imaging technique that generates volumetric 
angiography images in a matter of seconds. OCTA is quick and non-invasive, and 
provides volumetric data with the clinical capability of specifically localizing and 
delineating pathology along with the ability to show both structural and blood 
flow information. 
 
It was described first in 2006 but its use in ocular diseases started to be 
explored only in 2013. The technology first became commercially available for 
use in practice, only in 2014 with the introduction of the Avanti OCT-A 
22	
	
(Optovue Inc., USA) (34) 
 
Unlike traditional angiography with fluorescein, this technology does not 
require the injection of extrinsic contrast agent. OCTA detects the motion of red 
blood cells as intrinsic contrast and is sensitive to both transverse and axial flow 
in time. This is made possible by the use of high speed of Fourier-domain OCT 
(>50 kHz), which allows multiple cross-sectional images to be obtained at the 
same location to detect relative motion in vessels which can be superimposed to 
give color-coded flow information over gray scale structural information. Thus, 
both blood flow and retinal structural information may be presented together. 
OCTA generates a data cube, segmentation, and en face presentation of vascular 
perfusion at various layers of the retina and can summarize the flow information 
at relevant anatomic layers or slabs. These en face images can then be used to 
visualize the individual vascular plexuses at various levels of depth depending 
on the condition of interest.  
 
Of practical importance is the fact that existing OCT machines can be 
upgraded to perform angiography and use either the Doppler shift or variations 
in speckle pattern. Both varieties of Fourier-domain OCT, spectral or swept 
source are used.  
 
Split-spectrum amplitude decorrelation angiography is an algorithm that 
is capable of flow detection at both the ONH and at the macula and quantifies 
23	
	
the data as both flow index and vessel density. 
 
For diagnosis in patients with retinal pathologies, the introduction of 
OCT-A has been a huge advancement as it provides both functional and 
morphological analysis of the retina from a single dye-less examination. In the 
case of ONH microvasculature, the network is so fine and tightly arranged that 
it could not been visualized with traditional fluorescein angiography. OCT 
Angiography provides more confidence than the tried and tested, older testing 
methods. (63) 
 
 There are several studies, which have used OCTA to evaluate the vascular 
changes in early glaucoma patients, suspects and normals. 
 
Adeleh Yarmohammadi et al (57) studied Two hundred sixty-one eyes of 
164 healthy, glaucoma suspect, and open-angle glaucoma (OAG) participants, 
and found that age-adjusted mean vessel density was significantly lower in OAG 
eyes compared with glaucoma suspects and healthy eyes. Optical coherence 
tomography angiography vessel density had similar diagnostic accuracy to RNFL 
thickness measurements for differentiating between healthy and glaucoma eyes. 
 
Liang Liu et al (64) studied 12 glaucomatous eyes and 12 age-matched 
normal eyes, and found a dense micro vascular network around the disc in normal 
eyes, compared to visibly attenuated micro vascular network in glaucomatous 
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eyes. They concluded that reduced peri-papillary retinal perfusion in 
glaucomatous eyes can be visualized as focal defects and quantified as peri-
papillary flow index and peri-papillary vessel density, with high repeatability and 
reproducibility. 
 
Handan Akil et al (65) studied 56 eyes in total (20 eyes with mild POAG, 
20 pre-perimetric glaucoma eyes, and 16 age-matched normal eyes as controls) 
and found a statistically significant difference for the peri-papillary vessel 
density, optic nerve head vessel density, and papillary vessel density among all 
the groups, and concluded that the three groups could be differentiated on the 
basis of OCTA derived retinal vessel density measurements. 
 
C. Lommatzsch et al (66) studied a total of 68 eyes (34 eyes diagnosed 
with glaucoma and 34 healthy control eyes) and demonstrated that peri-papillary 
total flow density was significantly different in glaucoma eyes from healthy eyes. 
 
These studies have all been done in Caucasian eyes. We want to acquire 
more data about the perfusion of the optic disc and peri-papillary retina in 
glaucomatous eyes in the Indian population. 
 
 Based on this current study, we aim to develop OCT-A as a new imaging 
target for early diagnosis and management of glaucoma. 
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MATERIALS AND METHODS 
 
 This is a prospective, observational study, conducted in the out-patient 
department of a tertiary eye care hospital namely- Department of Ophthalmology, 
Schell Eye Hospital, CMC Vellore, This study is done by capturing and analyzing 
OCT angiography images, comparing differences in retinal vascular densities 
with the OCT RNFL thickness (structural parameter) and Visual field testing 
results (functional parameter) between the three groups namely normal, glaucoma 
suspects (Ocular hypertensives) and diagnosed glaucoma patients. There will be 
no follow up required. All investigations will be completed in the same visit. 
 
Participants: 
 All glaucoma suspects (Ocular hypertensives), age matched normals and 
diagnosed glaucoma patients between 30- 60 years of age fulfilling the inclusion 
criteria and willing to participate were invited to participate in the study.  Notices 
were posted in all the outpatient rooms to remind doctors to refer patients for 
study. Those patients, who were willing, then underwent a detailed eye 
examination with their respective doctors and then referred to the Primary 
Investigator (PI) for this study.  
 The PI then got an informed consent from the participant. PI assessed the 
patient’s eligibility to be recruited in the study, based on the inclusion and 
exclusion criteria mentioned below. Informed consent was taken in Tamil or 
English depending on the language they could understand. 
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INCLUSION CRITERIA 
Diagnostic criteria for glaucoma patients: - 
1) The presence of characteristic glaucomatous optic disc damage and abnormal 
thinning of the circum-papillary RNFL; 
2) Visual field defects consistent with glaucoma, confirmed on at least two 
visual field examinations; only mild- moderate stage POAG eyes based on 
Hoddap-Anderson-Parrish scale were included in our study as measured by 
visual field mean deviation scores (MD up to -12.0 dB). 
3) Open angles on gonioscopy; 
4) Patients who had been diagnosed as POAG before and were already on anti-
glaucoma medications. 
5) No history of any other ocular or systemic diseases causing non-
glaucomatous optic nerve damage. 
Diagnostic criteria of glaucoma suspects: - 
1) Patients who did not meet the previously stated definition of glaucoma. 
2) IOP >21 mm of hg (Ocular hypertension) 
3) Absence of clinically detectable glaucomatous optic nerve damage, or 
retinal nerve fiber layer defects. 
4) Absence of detectable visual field defects. 
Diagnostic criteria for the normals (Controls): - 
1) IOP of < 21 mmHg, 
2) Normal appearing optic nerve head, intact neuroretinal rim 
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3) Normal RNFL thickness. 
4) Normal standard automated perimetry (defined as a glaucoma hemi field 
test within normal limits and a pattern standard deviation within 95% 
confidence-interval limits) 
 
Exclusion criteria FOR ALL CATEGORIES 
(1) Best-corrected visual acuity less than 6/18, 
(2) Age younger than 30 years or older than 70 years, 
(3) Refractive error greater than +3.00 diopter (D) or less than − 6.00 D, 
(4) Previous intraocular surgery except for uncomplicated cataract extraction 
with posterior chamber intraocular lens implantation (less than 3 months 
post any intraocular procedure). 
(5) Any fundus pathology – Age related Macular degeneration, Diabetic 
retinopathy (Any stage), and Vein and artery occlusions. 
(6) Disc pathologies, non-glaucomatous conditions that may cause optic disc 
abnormalities 
(7) Non-glaucomatous conditions that may cause VF loss (Optic neuritis, 
anterior ischemic optic neuropathy, Retinitis pigmentosa, optic pathway 
lesions) 
(8) Inability to perform reliably, on automated visual field-testing. 
 
One eye from each participant  was imaged and analyzed in a random manner. 
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The following variables were defined before measurement: 
Visual field Mean Deviation (dB)  
Overall mean deviation indicates any overall depression (or elevation) of the 
patient's hill of vision. A positive number indicates a better than normal field 
(elevation of the hill of vision). A negative number indicates a depression of hill 
of vision. It is categorized as normal, or abnormal at a p-value of 5, 2, 1, or 0.5%, 
which lower p values corresponding with greater clinical significance and a lower 
likelihood that the result occurred by chance. 
 
Visual field Pattern Standard Deviation (dB) 
Indicates any isolated differences in a particular field. It highlights any 
irregularity in the visual field, irrespective of any overall depression. Overall 
pattern standard deviation is categorized as normal, or abnormal at a p-value of 5, 
2, 1, or 0.5%, which lower p values corresponding with greater clinical 
significance and a lower likelihood that the result occurred by chance. 
 
Cup/Disc Ratio 
Ratio of the vertical size of the cup (in mm) to the vertical size of the entire disc 
(in mm) 
Mean RNFL thickness (µm) 
The mean of the retinal nerve fiber layer thickness, calculated by the OCT 
machine 
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Superior RNFL thickness (µm)  
Mean of the retinal nerve fiber layer thickness, in the superior hemi-retina. 
Inferior RNFL thickness (µm) 
Mean of the retinal nerve fiber layer thickness, in the inferior hemi-retina. 
Optic nerve head area vessel density (%) (VdONH) 
Density of the microvasculature at the optic nerve head area, which will be 
calculated by image analysis. 
Peri-papillary area vessel density (%) (VdPPA) 
Density of the microvasculature at the peri-papillary area (700-micron wide 
elliptical annulus centered on the disc), which will be calculated by image 
analysis. 
Papillary area vessel density (%) (VdPA) 
Density of the microvasculature at the papillary area (3 mm circular region 
centered on the ONH), which will be calculated by image analysis. 
 
Superior Papillary area vessel density (%) (VdSPA) 
Density of the microvasculature at the superior papillary area (superior hemi-
retina), which will be calculated by image analysis. 
Inferior Papillary area vessel density (%) (VdIPA) 
Density of the microvasculature at the inferior papillary area (inferior hemi-
retina), which will be calculated by image analysis. 
30	
	
Diagnostic Criteria – 
Table 4: Glaucoma Grading Scale (Hodapp-Anderson-Parrish Criteria) (67) 
Stage Humphrey  
MD score 
Additional Criteria 
(At least 1 of the listed criteria must apply) 
Stage 0: 
No or 
Minimal 
Defect 
  
Stage 1: 
Early Defect 
≥ -6.00 dB • A cluster of ≥ 3 points on the pattern deviation 
plot in an expected location of the visual field 
depressed below the 5% level, at least one of 
which is depressed below the 1% level 
 
• CPSD/PSD significant at P<0.05 
 
 
• GHT Outside Normal Limits 
Stage 2: 
Moderate 
Defect 
≥ -6.00 to -
12.00 dB 
• ≥ 25% but <50% of points on the pattern 
deviation plot depressed below the 5% level, and 
≥15% but <25% of points depressed below the 
1% level 
 
• At least 1 point within the central 5° with 
sensitivity of <15 dB but no points in the central 
5° with sensitivity of <0 dB 
 
• Only 1 hemi field containing a point with 
sensitivity <15 dB within 5° of fixation 
Stage 3: 
Advanced 
Defect 
≥ -12.01 to 
-20.00 dB 
• ≥ 50% but <75% of points on pattern deviation 
plot depressed below the 5% level and ≥25% but 
<50% of points depressed below the 1% level 
 
• Any point within the central 5° with sensitivity <0 
dB 
 
• Both hemi fields containing a point(s) with 
sensitivity <15 dB within 5° of fixation 
Stage 4: 
Severe 
Defect 
≥ -20.00 
dB 
• ≥ 75% of points on pattern deviation plot 
depressed below the 5% level and ≥50% but 
<50% of points depressed below the 1% level 
 
• At least 50% of points within the central 5° with 
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sensitivity <0 dB 
 
• Both hemi fields containing >50% of points with 
sensitivity <15 dB within 5° of fixation 
Stage 5: 
End-Stage 
Disease 
 Unable to perform HVFA in worst eye due to central 
scotoma or worst eye VA 6/60 or worse due to POAG. 
Fellow eye may be at any stage 
 
DETAILED DIAGRAMMATIC ALGORITHM OF THE STUDY 
  All glaucoma suspects, age matched normals and diagnosed glaucoma patients 
between 30- 70 years of age fulfilling the inclusion criteria and willing to participate 
will be recruited to participate in the study. 
All glaucoma suspects, age matched normals and diagnosed glaucoma patients 
between 30- 60 years of age fulfilling the inclusion criteria and willing to participate 
will be recruited to participate in the study. 
The PI will perform detailed anterior segment examination, Intraocular pressure 
measurement with Goldman applanation tonometer, Gonioscopy with non-
indentation 2 mirror gonioscope, slit lamp biomicroscopic examination of the optic 
disc as per protocol and document Systemic co-morbidity and blood investigations 
The Optometrist will do investigations – 
Optic nerve head photograph, central corneal thickness measurement, automated 
perimetry with Humphry field analyzer, Optical coherence tomography analysis of 
the retinal nerve fiber layer thickness, Optical coherence tomography angiography 
analysis of the optic nerve head vasculature, papillary vasculature and peri-papillary 
vasculature photographs. 
PI will then analyze the collected data and calculate the vascular density in the optic 
nerve head area, papillary area and the peri-papillary area by quantitative analysis of 
vessel density in the images using publicly available ImageJ Software and with a 
plug-on Fuji program, average vessel density percentage was determined from the 
vessels of each area. 
PI will present the data to the co-investigators for interpretation and comparison 
	
Data entered in Epi-data and analyzed using STATA /IC 15.0 software 
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STUDY METHODOLOGY:  
  After taking the Informed consent, data regarding inclusion and exclusion 
criteria was obtained by a detailed history and clinical examination of the patients 
by the PI. Data regarding confounding factors was obtained by a detailed 
questionnaire. 
 
Potential confounders – include age, gender, diabetes mellitus, hypertension, 
hypercoagulable states and systemic medications. 
 
  The patients who were found suitable for the study were asked a few 
questions regarding their demographic Data, like Age, Gender, Phone Number, 
Address, Hospital Number, Ocular complaints, if any, past history of any ocular 
surgery/treatment, systemic co-morbidities of patients suffering from Diabetes 
Mellitus (DM), Hypertension (HTN), Ischemic Heart Disease (IHD), Asthma and 
the duration of their present ailments were also noted. If the patient is already a 
diagnosed Glaucoma patient, then name and number of anti- glaucoma 
medications that are being taken and duration of use were noted by PI and all the 
data captured was entered in the proforma and stored in separate files. 
 
  Then the patients underwent detailed anterior segment examination, 
Intraocular pressure measurement with Goldman applanation tonometer, 
Gonioscopy with non-indentation 2 mirror gonioscope, slit lamp biomicroscopic 
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examination of the optic disc, disc photograph, Disc diameter measurement and 
the readings were entered by PI in the proforma. 
  
Data Sources/measurement 
• Ocular examination, measurement of IOP and gonioscopy, was done by 
the PI. 
• Intra-ocular pressure was measured by Goldman applanation tonometry 
(Model AT 900) with a Haag Streit slit lamp biomicroscope (BM 900), 
which is the gold standard for IOP measurement. 
• Gonioscope used was a 2 mirror non-indentation indirect gonioscope 
(Volk G-2 Two-Mirror Glass Gonio Lens, Germany) 
 
All Measurements were done by the primary investigator and in the same 
machine. 
 
Investigations performed by trained and experienced optometrist: 
• CCT (Central Corneal Thickness) measurement by Tomey ultrasound 
instrument. 
 
• Visual field tests were performed with the Humphrey Field Analyzer II (Carl 
Zeiss Meditec, Inc). The system was set for the 24±2 threshold test, size III 
white stimulus, and SITA-standard algorithm. 
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• RNFL (Retinal Nerve Fiber Layer) thickness, from a 3.4-mm diameter circle 
scan centered on the disc, was assessed with SD-OCT (TOPCON DRI OCT 
Triton Plus). 
 
 
• Optical coherence tomography angiography (OCT-A) scans were performed 
using the Swept- Source Optical Coherence Tomography (SSOCT-A -- DRI 
OCT TRITON Plus, TOPCON Inc, Tokyo, Japan) with a central wavelength 
of 1050 nm light source and scanning speed of 100,000 A scans/ sec. The 
optic disc region was imaged using a 3 x 3 mm scan.  Custom grading 
software of the device used to generate the maps. En-face images of the 
vasculature were generated from the optic nerve and retinal layers and 
collapsed into a single two-dimensional image set, between the internal 
limiting membrane and retinal pigment epithelium using automated layer 
segmentation OCT instrument software (IMAGEnet 6 V.1.14.8538). 
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IMAGE PROCESSING AND QUANTITATIVE ANALYSIS: 
 
 En face scans that were acquired in the glaucoma suspects, age matched 
controls and glaucoma patients were further processed and quantitative analysis 
of the vessel density performed using the publicly available ImageJ software. 
 
 Vessel density ratio for each region of interest was calculated by dividing 
the vessel area by total area of the entire image *100 % using Fuji Program 
(Plug-in Module for ImageJ software). This was done for the entire image as well 
as 3 regions of interest: - 
 
1) Papillary region (3 mm circular region centered on the ONH), 
2) Peri-papillary region (700-micron wide elliptical annulus centered on the disc) 
3) The optic nerve head 
 
 Also, since mild glaucoma often presents with focal, rather than global 
defects, we divided the vessel intensity ratio for the papillary region into superior 
and inferior domains and then performed the calculations. 
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ANALYSIS OF IMAGE USING IMAGEJ SOFTWARE 
ImageJ is an free, open source, Java-based image processing program 
developed at the National Institutes of Health and the Laboratory for Optical and 
Computational Instrumentation (LOCI, University of Wisconsin). 
 
It can display, edit, analyze, process, save, and print 8-bit color and gray 
scale and various other types of images and can be used to manipulate these 
images to calculate area and pixel value statistics of user defined selections. 
 
The vessel analysis protocol uses the following formula to calculate vessel 
density metrics: - 
 
 
Firstly, The ImageJ software is to be downloaded and installed onto the 
computer, along with the Vessel analysis plugin. (Both available publicly, as 
open source, free of cost). Once the plugin is installed, the vessel analysis tab will 
appear listed near the bottom of the ‘Plugins’ drop down menu. 
Available here: - 
http://imagej.net/Fiji/Downloads 
http://imagej.net/File:Vessel_Analysis.zip 
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Colour Plate 5: ImageJ Software desktop program application window 
 
Colour Plate 6: Location of Vascular density tab, in the tool bar 
The layout of the image acquisition and viewing software in the OCT 
Angiography machine (Topcon DRI OCT Triton plus) shows all the OCTA 
images at different sections. 
 
In the first square, seen to the left, we set the thickness of the section to include 
all the layers/scans from Internal limiting membrane to retinal pigment 
epithelium, thus creating a composite image containing the combination of all the 
microvasculature maps captured at different levels by the machine, between the 
two set boundaries. 
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Colour Plate 7: Layout of data viewer on DRI OCT Triton plus, showing the 
microvascular network in OCTA images at different sections, the colour vessel 
density map, and the colour disc photograph 
The composite image formed is like so: - 
 
Colour Plate 8: 2-dimentional composite OCTA image formed by 
superimposition of the micro vascular network maps of all the sections acquired 
between internal limiting membrane to retinal pigment epithelium. 
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This image is a 3x3 mm scan of the ONH and peri-papillary micro vascular 
network, of 320x320 pixel resolution. 
 
This image is copied onto the computer and opened in ImageJ software. 
The next step is to create a mesh framework of the micro vascular grid, before 
vessel density analysis, to delineate/ highlight only the micro vascular network. 
This is done by background subtraction and then, by converting the background 
subtracted image into an 8 bit binary (black and white) image from the unedited 
RGB image. This can be done by using the ‘Binary image’ option under the 
‘Process’ tab, as shown here. 
 
Colour Plate 9: Location of Background subtraction tab and binary map tab on 
toolbar in ImageJ 
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Colour Plate 10: Composite OCTA image, after background subtraction, 
conversion to binary image and preparation of micro vascular framework mesh. 
 
Next, we start the vessel density analysis. The image is first edited by cropping 
out only the required areas of interest. The required area is selected using the 
‘Oval’, ‘Polygon’ or the ‘Free hand’ selection tools in the ImageJ ‘Software’ tabs, 
after measuring the proper dimensions for the area of interest. 
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Then, the Vessel density in the area of interest, in each of these cropped pictures 
in calculated, by software analysis using ImageJ. The result is displayed as 
percentage area (%area) 
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Colour Plate 12: Window displaying the vascular density of the selected area of 
interest 
 
This process is repeated for the OCT Angiography image of every selected eye, 
and the measurements are tabulated in Spreadsheet format by entering into 
Epidata. 
 
BIAS: 
• Names of patients will not be recorded in the spreadsheet for analysis – 
patients will be identified only with their unique identification hospital 
number. 
• Visual acuity will be recorded as per department protocol by the respective 
optometrist prior to recruitment into the study 
• Clinical examination of the patient and recording of findings will be done by 
the PI for uniformity of diagnosis 
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• Image analysis will be done at the end of the recruitment period or at least 2 
weeks following the recruitment of the patient 
 
SAMPLE SIZE 
  A sample of size 16 in each group is needed to detect 6% difference in 
peri-papillary vascular density between glaucoma suspects and normals 
(controls), with 80% power and 5% level of significance. We assume that mean 
and standard deviation of the peri-papillary vascular density was 86% and 92% 
with standard deviation of 6 and 4 respectively. We also consider an equal 
number in the diagnosed glaucoma group as a 3rd group for comparison. 
 
QUANTITATIVE VARIABLES 
 
All quantitative variables were measured as per the machine protocol and 
documented as raw values. 
Age was considered to the nearest whole number and matching was done within 
±2 years, or the measurements were statistically adjusted for age. 
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STATISTICAL METHODS 
 
Data were summarized using mean (SD)/ Median (range) for continuous 
variables and categorical data were expressed as frequency along with 
percentage. The continuous variables among the groups were compared using 
ANOVA followed by Bonferroni as post hoc test. The categorical associations 
or comparisons with the three groups were performed using Chi-square test. 
The discriminating ability of vascular density parameters for normals compared 
with suspects (Ocular hypertensives); as well the suspects compared with 
diseased (Early POAG patients) were presented by constructing a Receiver 
Operating Characteristic (ROC) curve.  The Area under curve (AUC) along 
with Standard Error (SE), Sensitivity and Specificity were reported for the 
optimal cut-off decided. All the analysis were performed using STATA /IC 15.0 
software. 
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RESULTS AND ANALYSIS 
 
A total of 54 eyes of 54 patients were studied. Table 5 shows the number of patients in 
each group.  
 
Of the 54 eyes of 54 patients, 19 eyes were of the normal controls, 18 eyes were of the 
patients with Ocular hypertension and 17 eyes were of patients with Primary Open 
Angle Glaucoma. 
Table 5: Distribution of patients and eyes in each group 
 
Group Normals O-HTN Group POAG Group 
Number of patients 
(Eyes) (n) 19 (19) 18 (18) 17 (17) 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
 
 
Of the 54 patients studied, totally, 25 (46.30%) were males and 29 (53.70%) were 
females. Table 6 shows the sex distribution among each of the groups studied. 
Table 6: Sex distribution among the various groups 
 
Sex Groups Total 
Normals O-HTN Group POAG Group 
Male 
Number (%) 6 (31.58%) 8 (44.44%) 11 (64.71%) 25 (46.30%) 
Female 
Number (%) 13 (68.42%) 10 (55.56%) 6 (35.29%) 29 (53.70%) 
Total 
Number (%) 19 (100%) 18 (100%) 17 (100%) 54 (100%) 
O-HTN – Ocular Hypertension 
POAG – Primary Open Angle Glaucoma 
 
There was no statistically significant difference in the distribution of males and 
females between the three groups. (p = 0.136) 
 
46	
	
Of the 54 eyes of the 54 patients studied, right eyes were 26 (48.15%) and left eyes 
were 28 (51.85%). Table 7 shows the eye distribution among each of the groups 
studied. 
 
Table 7: Distribution of right and left eye among the various groups 
  
Eye Groups Total 
Normals O-HTN Group POAG Group 
Right Eye 
Number (%) 11 (57.89%) 7 (38.89%) 8 (47.06%) 26 (48.15%) 
Left Eye 
Number (%) 8 (42.11%) 11 (61.11%) 9 (52.94%) 28 (51.85%) 
Total 
Number (%) 19 (100.00%) 18 (100.00%) 17 (100%) 54 (100%) 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
 
There was no statistically significant difference in the distribution of eyes (Right or 
Left) between the two groups. (p = 0.509) 
 
Age distribution of patients in each group is seen in Table 8 
 
Table 8: Age distribution of patients in each group Visual Field Pattern 
Standard Deviation 
 
Age Groups p Value 
Normals O-HTN Group POAG Group 
Number 19 18 17 0.067 
Mean Age  
(± SD) 
48.74  
(±12.10) 
51.94 
(± 13.33) 
58.00 
(± 9.33) 
Minimum to 
Maximum Age 30 to 68 30 to 70 42 to 70 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
 
There was no statistically significant difference in age seen among the three groups (p 
= 0.067). However, the patients with primary open angle glaucoma were in general, 
slightly older than the patients in the O-HTN and Normals group. 
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The Mean Ocular Perfusion Pressure (MOPP) was calculated for each patient, by 
measuring the BP and the IOP at the time of examination and was calculated by using 
the below formula: - 
 
 
Where, MAP = Mean Arterial Pressure; IOP = Intraocular Pressure 
 
 
Where, SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure 
 
The distribution of MOPP, among the groups is shown in Table 9 
 Table 9: Distribution of MOPP in each group 
 Groups 
Normals  
(n =19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean MOPP 
(± SD)(Mm Hg) 
54.35 
(± 4.25) 
46.18 
(± 6.38) 
48.95 
(± 3.02) 
Minimum to 
Maximum MOPP 
(Mm Hg) 
44.88 to 63.55 33.77 to 56.00 45.77 to 56.44 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
 
54.35	
46.18	
48.95	
42	
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Mean	MOPP	
Fig.13- Bar Diagram Of Distribution Of Mopp in mm Hg in 
Each Group 
Normals	 O-HTN	Group	 POAG	Group	
Mean	Ocular	Perfusion	Pressure	(MOPP)	=	⅔	X	
 
[MAP	–	IOP] 
Mean	Arterial	Pressure	(MAP)	= DBP	+	(1/3)(SBP	-	DBP) 
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In our sample groups, the difference between mean MOPP in the O-HTN group 
and Normals was statistically significant. (8.16 mm Hg lower in O-HTN group) 
(p = <0.01); And the difference between the mean MOPP in the POAG group 
and Normals was also statistically significant. (5.40 mm Hg lower in POAG 
group)(p = <0.01).But the difference in mean MOPP between the O-HTN group 
and POAG group was not significant statistically (p = 0.278) 
 
Out of the 54 eyes of 54 patients, a total of 19 (35.19%) patients were on Anti-
glaucoma medications, majority being from the POAG group (Table 10) 
Table 10: Use of Anti Glaucoma Medications in each group 
 
 Groups 
Normals O-HTN Group POAG Group 
Number of patients 
on AGM / Total 
number of patients in 
Group  
(%)  
0 / 19  
 
 
 
(0%) 
3 / 18 
 
 
 
(16.67%) 
16 / 17 
 
 
 
(94.12%) 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
AGM – Anti Glaucoma Medications 
 
 
In the Vision assessment for each of the patients included in the study, Best 
Corrected Visual Acuity was measured from Snellen’s visual acuity and was 
converted to LogMar visual acuity for statistical analysis. The mean LogMar 
visual acuity of the three groups was given in Table 11. 
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Table 11: Distribution of BCVA in each group 
 
BCVA Groups p Value 
Normals O-HTN Group POAG Group 
Number 19 18 17 <0.01 
Mean BCVA 
(± SD) 
0.00  
(± 0.00) 
0.11 
(± 0.11) 
0.12 
(± 0.12) 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
BCVA – Best Corrected Visual Acuity 
 
In our sample groups, the difference between mean BCVA in the O-HTN group 
and Normals was statistically significant (p = <0.01); and the difference 
between the mean BCVA in the POAG group and Normals was also statistically 
significant (p = <0.01). But the difference in mean BCVA between the O-HTN 
group and POAG group was not significant statistically (p = 1.00). 
 
Intraocular Pressure (IOP) measured at the time of examination of the patients 
was analyzed and the distribution was found to be as follows (Table 12):  
Table 12: Distribution of IOP in each group 
 
IOP Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean IOP 
(Mm Hg) 
(± SD) 
13.21  
(± 2.27) 
 27.50 
(± 3.70) 
 26.47 
(± 2.90) 
<0.01 
Minimum to 
Maximum IOP 
(Mm Hg) 
08 to 16 24 to 36 22 to 32 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
IOP - Intraocular Pressure 
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In our sample groups, the difference between mean IOP in the O-HTN group and 
Normals was statistically significant (p = <0.01); and the difference between the mean 
IOP in the POAG group and Normals was also statistically significant (p = <0.01).But 
the difference in mean IOP between the O-HTN group and POAG group was not 
significant statistically (p = 0.947) 
 
Differences in the Vertical disc diameter (VDD) and Cup: Disc Ratio (CDR) between 
the groups was also measured and the results are as follows (Table 13 and 14):  
Table 13: Distribution of VDD in each group 
 
 Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VDD (mm) 
(± SD) 
 1.96 
(± 0.19) 
 1.91 
(± 0.14) 
 1.95 
(± 0.23) 
0.714 
Minimum to 
Maximum VDD(mm) 
1.65 to 2.34 1.69 to 2.21 1.65 to 2.47 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VDD – Vertical Disc Diameter 
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FIG 14: Bar Diagram Of Distribution Of IOP In Each Group 
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There was no statistically significant difference in the Vertical Disc Diameter 
between the three groups. (p = 0.714) 
Table 14: Distribution of CDR in each group 
 Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean CDR 
 (± SD) 
 0.35 
(± 0.10) 
 0.39 
(± 0.14) 
 0.74 
(± 0.07) 
<0.01 
Minimum to 
Maximum CDR 
0.10 to 0.50 0.20 to 0.70 0.60 to 0.80 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma, 
CDR – Cup: Disc Ratio 
 
 
 
There was a statistically significant difference in the Cup: Disc Ratio (CDR) between 
the Normals and POAG group (p = <0.01) and also a statistically significant difference 
between the O-HTN Group and POAG group (p = <0.01) 
But there was no statistically significant difference in the CDR between Normals and 
O-HTN Group. (p = 0.754) 
The Automated Perimetry testing by Humphrey Field Analyzer, done for all the 54 
patients included in the study. The machine calculation of the Mean Deviation (MD) 
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Fig	15-	DistribuOon	Of	Mean	Cup	Disc	RaOo(CDP)	In	Each	
Group	
NORMALS	 O-HTN	GROUP	 POAG	GROUP	
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and Pattern Standard Deviation (PSD) for each eye tested, was analyzed. The results 
are as follows (Table 15): - 
Table 15: Distribution of Visual Field Mean Deviation (MD) and Pattern 
Standard Deviation (PSD) in each group 
 Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean MD 
(± SD)(in dB) 
- 4.82 
(± 1.85) 
- 4.48 
(± 1.72) 
- 8.39 
(± 1.58) 
<0.01 
Mean PSD 
(± SD)(in dB) 
1.87 
(± 0.74) 
2.69 
(± 1.72) 
4.85 
(± 2.59) 
<0.01 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
MD - Visual Field Mean Deviation, PSD - Visual Field Pattern Standard Deviation 
 
There was a statistically significant difference in the Visual Field Mean 
Deviation (MD) between the Normals and POAG group (p = <0.01) and also a 
statistically significant difference between the O-HTN Group and POAG group 
(p = <0.01). But there was no statistically significant difference in the Visual 
Field Mean Deviation (MD) between Normals and O-HTN Group. (p = 1.00) 
When comparing the Visual Field Pattern Standard Deviation (PSD), 
there was a statistically significant difference between the Normals and POAG 
group (p = <0.01) and also a statistically significant difference between the O-
HTN Group and POAG group (p = <0.01). But there was no statistically 
significant difference in the Visual Field Pattern Standard Deviation (PSD) 
between Normals and O-HTN Group. (p = 0.521) 
 
 
Next, the Retinal Nerve Fiber Layer Thickness (RNFL Thickness), 
measured by Optical Coherence Tomography (OCT), was analyzed. The 
measurements were recorded as Mean RNFL Thickness, and also separately as 
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Superior and Inferior RNFL Thickness. The analysis showed the following 
results (Table 16): - 
Table 16: - Distribution of Mean, Superior and Inferior RNFL Thickness 
in each group 
RNFL Thickness Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean of Mean 
RNFL Thickness  
(± SD)(µm) 
109.95 
 
(± 11.05) 
100.00 
 
(± 13.02) 
80.27 
 
(± 13.52) 
<0.01 
Mean of Superior 
RNFL Thickness  
(± SD)(µm) 
134.63 
 
 (± 21.74) 
125.89 
 
 (± 18.71) 
98.53 
 
 (± 26.26) 
<0.01 
Mean of Inferior 
RNFL Thickness  
(± SD)(µm) 
145.00 
 
(± 14.76) 
131.22 
 
(± 16.15) 
89.00 
 
(± 13.22) 
<0.01 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
RNFL – Retinal Nerve Fiber Layer 
 
 
There was a statistically significant difference in the Mean RNFL Thickness 
between the Normals and POAG group (p = <0.01) and also a statistically significant 
difference between the O-HTN Group and POAG group (p = <0.01). But there was no 
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FIG	16-	DISTRIBUTION	OF	MEAN	OF	MEAN,	SUPERIOR	
AND	INFERIOR	RNFL	THICKNESS	IN	µm	IN	EACH	GROUP	
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statistically significant difference in the Mean RNFL Thickness between Normals and 
O-HTN Group. (p = 0.06) 
When comparing the Superior RNFL Thickness, there was a statistically 
significant difference between the Normals and POAG group (p = <0.01) and also a 
statistically significant difference between the O-HTN Group and POAG group (p = 
<0.01). But there was no statistically significant difference in the Superior RNFL 
Thickness between Normals and O-HTN Group. (p = 0.720). 
 
When comparing the Inferior RNFL Thickness, there was a statistically 
significant difference between the Normals and POAG group (p = <0.01) and also a 
statistically significant difference between the O-HTN Group and POAG group (p = 
<0.01) 
 
An important difference noted was that there was a statistically 
significant difference in the Inferior RNFL Thickness between the Normals and 
O-HTN Group. (p = 0.020). 
 
 
Finally, the Vascular density measurement was done by analysis of the Optical 
Coherence Tomography Angiography images of the Optic Nerve Head and 
Papillary area; and the entire image was divided and analysis was done in the 
Optic Nerve Head area (VdONH), Peri-papillary area (VdPPA), Papillary area 
(VdPA), Superior Papillary (VdSPA) and Inferior Papillary (VdIPA) areas. The 
results were as follows: - 
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Table 17: Distribution of Optic Nerve Head area (VdONH) Vascular 
Density measurements in each group 
VdONH Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VdONH 
(± SD)(%Area) 
72.92 
(± 2.44) 
64.50 
(± 3.41) 
58.58 
(± 2.46) 
<0.01 
Minimum to 
Maximum 
VdONH(%Area) 
66.70 to 77.29 
 
57.49 to 68.94 54.08 to 
61.95 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VdONH - Optic Nerve Head area Vascular Density measurements 
 
 
There was a statistically significant difference in the Optic Nerve Head area 
(VdONH) Vascular Density measurements between the Normals and POAG 
group (p = <0.01), also a statistically significant difference between the O-HTN 
Group and POAG group (p = <0.01) and also a statistically significant 
difference between the Normals and O-HTN group (p = <0.01) 
The VdONH measurements, in the descending order of percentage area of 
Vascular density, were, Normals > O-HTN > POAG Group (in that order) and 
the difference was statistically significant between all three groups. (P = <0.01) 
72.92	
64.5	
58.58	
0	
10	
20	
30	
40	
50	
60	
70	
80	
MEAN	VdONH	(%	Area)	
FIG	17-	DistribuOon	Of	OPTIC	NERVE	HEAD	AREA	(VdONH)	
Vascular	Density	Measurements	In	Each	group	
NORMALS	 O-HTN	GROUP	 POAG	GROUP	
56	
	
Table 18: Distribution of Peri-Papillary area (VdPPA) Vascular Density 
measurements in each group 
VdPPA Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VdPPA 
(± SD)(%Area) 
74.09 
(± 2.03) 
66.54  
(± 1.48) 
59.18  
(± 2.57) 
<0.01 
Minimum to 
Maximum 
VdPPA (%Area) 
69.01 to 78.48 
 
63.06 to 68.90 54.68 to 63.32 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VdPPA - Peri-Papillary area Vascular Density measurements 
 
There was a statistically significant difference in the Peri-Papillary area 
(VdPPA) Vascular Density measurements between the Normals and POAG 
group (p = <0.01), also a statistically significant difference between the O-HTN 
Group and POAG group (p = <0.01) and also a statistically significant 
difference between the Normals and O-HTN group (p = <0.01) 
The VdPPA measurements, in the descending order of percentage area of 
Vascular density, were, Normals > O-HTN > POAG Group (in that order) and 
the difference was statistically significant between all three groups. (P = <0.01) 
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Table 19: Distribution of Papillary area (VdPA) Vascular Density 
measurements in each group 
VdPA Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VdPA 
(± SD)(%Area) 
74.01 
(± 1.45) 
66.47 
(± 2.26) 
59.25 
(± 2.33) 
<0.01 
Minimum to 
Maximum 
VdPA(%Area) 
71.42 to 76.87 
 
60.09 to 69.72 55.22 to 63.02 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VdPA - Papillary area Vascular Density measurements 
 
 
 
There was a statistically significant difference in the Papillary area (VdPA) 
Vascular Density measurements between the Normals and POAG group (p = 
<0.01), also a statistically significant difference between the O-HTN Group and 
POAG group (p = <0.01) and also a statistically significant difference between 
the Normals and O-HTN group (p = <0.01) 
The VdPA measurements, in the descending order of percentage area of 
Vascular density, were, Normals > O-HTN > POAG Group (in that order) and 
the difference was statistically significant between all three groups. (P = <0.01) 
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Table 20: Distribution of Superior Papillary area (VdSPA) Vascular 
Density measurements in each group 
 
VdSPA Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VdSPA 
(± SD)(%Area) 
73.10 
(± 2.45) 
66.28 
(± 2.87) 
59.72 
(± 1.75) 
<0.01 
Minimum to 
Maximum 
VdSPA(%Area) 
68.29 to 78.11 
 
58.73 to 69.73 56.31 to 62.53 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VdSPA – Superior Papillary area Vascular Density measurements 
 
There was a statistically significant difference in the Superior Papillary area 
(VdSPA) Vascular Density measurements between the Normals and POAG 
group (p = <0.01), also a statistically significant difference between the O-HTN 
Group and POAG group (p = <0.01) and also a statistically significant 
difference between the Normals and O-HTN group (p = <0.01).  
The VdSPA measurements, in the descending order of percentage area of 
Vascular density, were, Normals > O-HTN > POAG Group (in that order) and 
the difference was statistically significant between all three groups. (P = <0.01) 
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Table 21: Distribution of Inferior Papillary area (VdIPA) Vascular Density 
measurements in each group 
 
VdIPA Groups p Value 
Normals 
(n = 19) 
O-HTN Group 
(n = 18) 
POAG Group 
(n = 17) 
Mean VdIPA 
(± SD)(%Area) 
75.09 
(± 1.76) 
66.14 
(± 2.19) 
57.73 
(± 2.34) 
<0.01 
Minimum to 
Maximum 
VdIPA(%Area) 
72.42 to 77.85 
 
61.67 to 70.58 53.53 to 61.98 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
VdIPA – Inferior Papillary area Vascular Density measurements 
 
There was a statistically significant difference in the Inferior Papillary area 
(VdIPA) Vascular Density measurements between the Normals and POAG 
group (p = <0.01), also a statistically significant difference between the O-HTN 
Group and POAG group (p = <0.01) and also a statistically significant 
difference between the Normals and O-HTN group (p = <0.01) 
The VdIPA measurements, in the descending order of percentage area of 
Vascular density, were, Normals > O-HTN > POAG Group (in that order) and 
the difference was statistically significant between all three groups. (P = <0.01) 
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Next, for each of the areas of interest analyzed for Vascular density 
measurements, based on the distribution of above results, Receiver Operating 
Characteristic (ROC) Curves were constructed by plotting the True positive 
fraction (TPF) (Sensitivity) on the Y-Axis and False positive fraction (FPF)    
(1-Sensitivity) on the X – Axis. The sensitivities and specificities at each point 
along the curve were determined and the Cut-offs for each parameter, to 
differentiate between the two groups being compared, was determined based on 
the combination of maximum sensitivity and specificity. The ROC curve was 
described by its components; Area under the curve (AUC), Sensitivity at 
specified specificity and Partial Area under the curve. 
 
Firstly, The O-HTN Group was compared with the Normal Group, to determine 
the cut-off point, at each of the areas of interest. 
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ROC Curve 1: ROC Curve of Optic Nerve Head area (VdONH) Vascular 
Density measurements (O-HTN Group Vs. Normals) 
 
Table 22: Cut-off value for differentiating between O-HTN group and 
Normals using ONH Vascular density measurements (VdONH) 
 
VdONH O-HTN group Vs. Normals (95% Confidence Interval) (n = 37) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9854 
(0.0157) 
> 69.73% 100.00% 94.74% 
VdONH - Optic Nerve Head area Vascular Density measurements 
O-HTN – Ocular Hypertension,  AUC – Area under Curve 
SE – Standard Error 
 
Therefore a VdONH Vascular Density measurement above 69.73% suggests likely to 
be Normal and below suggests likely to be O-HTN. 
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ROC Curve 2: ROC Curve of Peri-Papillary area (VdPPA) Vascular 
Density measurements (O-HTN Group Vs. Normals) 
 
 
Table 23: Cut-off value for differentiating between O-HTN group and 
Normals using Peri-Papillary Vascular density measurements (VdPPA) 
 
VdPPA O-HTN group Vs. Normals (95% Confidence Interval) (n = 37) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
1.000 
 
(0.000) 
> 69.01% 100.00% 100.00% 
VdPPA – Peri-Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
AUC – Area under Curve,  SE – Standard Error 
 
Therefore a VdPPA Vascular Density measurement above 69.01% suggests likely to 
be Normal and below suggests likely to be O-HTN. 
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ROC Curve 3: ROC Curve of Papillary area (VdPA) Vascular Density 
measurements (O-HTN Group Vs. Normals) 
 
 
Table 24: Cut-off value for differentiating between O-HTN group and 
Normals using Papillary Vascular density measurements (VdPA) 
 
VdPA O-HTN group Vs. Normals (95% Confidence Interval) (n = 37) 
AUC  
(SE) 
CUT-OFF 
(%) 
SENSITIVITY SPECIFICITY 
1.000 
 
(0.000) 
> 71.42% 100.00% 100.00% 
VdPA – Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
AUC – Area under Curve 
SE – Standard Error 
 
Therefore a VdPA Vascular Density measurement above 71.42% suggests 
likely to be Normal and below suggests likely to be O-HTN. 
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ROC Curve 4: ROC Curve of Superior Papillary area (VdSPA) Vascular 
Density measurements (O-HTN Group Vs. Normals) 
 
 
 
 
Table 25: Cut-off value for differentiating between O-HTN group and 
Normals using Superior Papillary Vascular density measurements 
(VdSPA) 
 
VdSPA O-HTN group Vs. Normals (95% Confidence Interval) (n = 37) 
AUC  
(SE) 
CUT-OFF 
(%) 
SENSITIVITY SPECIFICITY 
0.9825 
(0.0185) 
> 70.03% 100.00% 94.74% 
VdSPA – Superior Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
AUC – Area under Curve, SE – Standard Error 
 
Therefore a VdSPA Vascular Density measurement above 70.03% suggests 
likely to be Normal and below suggests likely to be O-HTN. 
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ROC Curve 5: ROC Curve of Inferior Papillary area (VdIPA) Vascular 
Density measurements (O-HTN Group Vs. Normals) 
 
 
 
 
Table 26: Cut-off value for differentiating between O-HTN group and 
Normals using Inferior Papillary Vascular density measurements (VdIPA) 
 
VdIPA O-HTN group Vs. Normals (95% Confidence Interval) (n = 37) 
AUC  
(SE) 
CUT-OFF 
(%) 
SENSITIVITY SPECIFICITY 
1.0000  
 
(0.0000) 
> 72.42% 100.00% 100.00% 
VdIPA – Inferior Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
AUC – Area under Curve, SE – Standard Error 
 
Therefore a VdIPA Vascular Density measurement above 72.42% suggests 
likely to be Normal and below suggests likely to be O-HTN. 
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Next, the O-HTN Group was compared with the POAG Group, to determine the 
cut-off point, at each of the areas of interest. 
 
ROC Curve 6: ROC Curve of Optic Nerve Head area (VdONH) Vascular 
Density measurements (O-HTN Group Vs. POAG Group) 
 
 
Table 27: Cut-off value for differentiating between O-HTN group and 
POAG Group using ONH Vascular density measurements (VdONH) 
VdONH O-HTN group Vs. POAG group (95% Confidence Interval) (n = 35) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9052  
(0.0514) 
> 62.65% 100.00% 77.78% 
VdONH - Optic Nerve Head area Vascular Density measurements 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
AUC – Area under Curve,   SE – Standard Error 
 
Therefore a VdONH Vascular Density measurement above 62.65% suggests 
likely to be O-HTN and below suggests likely to be POAG. 
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ROC Curve 7: ROC Curve of Peri-Papillary area (VdPPA) Vascular 
Density measurements (O-HTN Group Vs. POAG Group) 
 
 
 
 
Table 28: Cut-off value for differentiating between O-HTN group and 
POAG Group using Peri-Papillary area (VdPPA) Vascular Density 
measurements 
VdPPA O-HTN group Vs. POAG group (95% Confidence Interval) (n = 35) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9967 
(0.0046) 
> 64.86 % 100.00% 94.44% 
VdPPA - Peri-Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension,  POAG – Primary Open Angle Glaucoma 
AUC – Area under Curve, SE – Standard Error 
 
Therefore a VdPPA Vascular Density measurement above 64.86% suggests 
likely to be O-HTN and below suggests likely to be POAG. 
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ROC Curve 8: ROC Curve of Papillary area (VdPA) Vascular Density 
measurements (O-HTN Group Vs. POAG Group) 
 
 
 
 
Table 29: Cut-off value for differentiating between O-HTN group and 
POAG Group using Papillary area (VdPA) Vascular Density 
measurements 
 
VdPA O-HTN group Vs. POAG group (95% Confidence Interval) (n = 35) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9837 
(0.0175) 
> 63.07 % 100.00% 94.44% 
VdPA - Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
POAG – Primary Open Angle Glaucoma 
AUC – Area under Curve, SE – Standard Error 
 
Therefore a VdPA Vascular Density measurement above 63.07 % suggests 
likely to be O-HTN and below suggests likely to be POAG 
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ROC Curve 9: ROC Curve of Superior Papillary area (VdSPA) Vascular 
Density measurements (O-HTN Group Vs. POAG Group) 
 
 
 
Table 30: Cut-off value for differentiating between O-HTN group and 
POAG Group using Superior Papillary area (VdSPA) Vascular Density 
measurements 
VdSPA O-HTN group Vs. POAG group (95% Confidence Interval) (n = 35) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9444  
 
(0.0442) 
> 65.07 % 100.00% 83.33 % 
VdSPA – Superior Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension, POAG – Primary Open Angle Glaucoma 
AUC – Area under Curve,  SE – Standard Error 
 
Therefore a VdSPA Vascular Density measurement above 65.07 % suggests 
likely to be O-HTN and below suggests likely to be POAG. 
70	
	
ROC Curve 10: ROC Curve of Inferior Papillary area (VdIPA) Vascular 
Density measurements (O-HTN Group Vs. POAG Group) 
 
 
 
Table 31: Cut-off value for differentiating between O-HTN group and 
POAG Group using Inferior Papillary area (VdIPA) Vascular Density 
measurements 
VdIPA O-HTN group Vs. POAG group (95% Confidence Interval) (n = 35) 
AUC  
(SE) 
CUT-OFF (%) SENSITIVITY SPECIFICITY 
0.9967 
 
(0.0046) 
> 62.16 % 100.00% 94.44 % 
VdIPA – Inferior Papillary area Vascular Density measurements 
O-HTN – Ocular Hypertension 
POAG – Primary Open Angle Glaucoma 
AUC – Area under Curve 
SE – Standard Error 
 
Therefore a VdIPA Vascular Density measurement above 62.16 % suggests 
likely to be O-HTN and below suggests likely to be POAG. 
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Table 32: Composite table showing Pairwise comparisons of Cut-off values 
of Vascular density measurements, to distinguish O-HTN from Normals 
and POAG Group 
Area Of Interest O-HTN Vs. Normals 
> = Normals 
< = O-HTN 
O-HTN Vs. POAG 
> = O-HTN 
< = POAG 
CUT-OFF AUC 
(SE) 
CUT-OFF AUC 
(SE) 
VdONH > 69.73% 0.9854 
 
(0.0157) 
> 62.65% 
 
0.9052  
 
(0.0514) 
VdPPA > 69.01% 1.000 
 
(0.000) 
> 64.86 % 
 
0.9967 
 
(0.0046) 
VdPA 
 
> 71.42% 
 
1.000 
 
(0.000) 
> 63.07 % 
 
0.9837 
 
(0.0175) 
VdSPA 
 
> 70.03% 0.9825 
 
(0.0185) 
> 65.07 % 
 
0.9444  
 
(0.0442) 
VdIPA 
 
> 72.42% 
 
1.0000  
 
(0.0000) 
> 62.16 % 0.9967 
 
(0.0046) 
 
 
ROC Curve 11 and 12: Composite ROC Curves of all areas of interest 
studied in comparison between O-HTN Vs. Normals (Right) and O-HTN 
Vs. POAG (Left) 
 
O-HTN Vs Normals 
 
O-HTN Vs POAG 
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Table 33: Comparative representation of distribution of Retinal Nerve 
Fiber Layer Thickness (RNFL Thickness) and Vascular Density in Overall 
Papillary, Superior and Inferior Papillary areas in each group. 
Area Of 
Interest 
Normals 
(n = 19) 
O-HTN 
(n = 18) 
POAG 
(n = 17) 
Mean of 
RNFL 
Thickness 
(µm) 
Mean 
Vessel 
Density 
(%Area) 
Mean of 
RNFL 
Thickness 
(µm) 
Mean of 
Vessel 
Density 
(%Area) 
Mean of 
RNFL 
Thickness 
(µm) 
Mean of 
Vessel 
Density 
(%Area) 
Papillary 
Area  
(Mean 
RNFL 
Thickness) 
109.95 74.01 % 100.00 66.47 % 80.27 59.25 % 
Superior 
Papillary 
Area 
(Superior 
RNFL 
Thickness) 
134.63 73.10 % 125.89 66.28 % 98.53 59.72 % 
Inferior 
Papillary 
Area 
(Inferior 
RNFL 
Thickness) 
145.00 75.09 % 131.22 66.14 % 89.00 57.73 % 
 
This table shows that, in the corresponding area of interest, as the RNFL 
thickness decreases, there is also a decrease in the Vessel Density measurement. 
 
The above data sets, comprising of 54 eyes of 54 patients, include 
patients with Diabetes and Systemic Hypertension. These systemic co-
morbidities have been known to produce vascular changes in end organs. 
Hence, excluding the patients with diagnosed Diabetes, Hypertension or both, 
from the original data set, we tabulated a separate dataset and the two data sets 
were compared for any differences in the vessel densities (Table 34).  
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Out of 54 patients, 8 had diabetes only, 10 had systemic hypertension 
only, and 6 had both diabetes and systemic hypertension. Therefore, excluding 
all these patients from the overall dataset, the new dataset formed, has n = 30 
patients. 
 
The comparison between the two datasets did not show much difference in the 
vessel densities, in all the areas of interest. 
Table 34: Comparison of the mean vascular densities between the old 
dataset (patients with DM and HTN), and the new dataset (No DM and 
HTN) 
 Old Dataset (DM+, HTN+, 
DM & HTN+) 
(n = 54) 
New dataset (DM-, HTN-, 
DM & HTN -) 
(n = 30) 
Mean VdONH  
(± SD) 
(%Area) 
65.60 %  
 
(± 6.56) 
66.68 % 
 
(± 7.01) 
Mean VdPPA 
(± SD) 
(%Area) 
66.88 
 
(± 6.47) 
68.09 % 
 
(± 6.95) 
Mean VdPA 
(± SD) 
(%Area) 
66.85 
 
(± 6.40) 
68.23 % 
 
(± 6.59) 
Mean VdSPA 
(± SD) 
(%Area) 
66.61 
 
(± 6.00) 
67.49 % 
 
(± 6.47) 
Mean VdIPA 
(± SD) 
(%Area) 
66.64 
 
(± 7.44) 
68.09 % 
 
(± 7.65) 
 
It is therefore likely that in our group of patients, diabetes and hypertension did 
not have a significant effect on the retinal vasculature and can be ignored as a 
potential confounding factor in analysis and conclusions. 
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DISCUSSION 
 
Glaucoma is a major cause of blindness in India and worldwide. On the 
basis of available data, there are about 11.2 million people in India, aged 40 
years and above, who are diagnosed cases of glaucoma. Primary open angle 
glaucoma has a prevalence of 6.48 million and the estimated number of primary 
angle closure glaucoma is 2.54 million. (68). 
 
 The burden on society, due to glaucoma as a disease, is monumental, and 
one is of the opinion that the current prevalence is a gross underestimation of 
the real picture. This is due to the lack of a reliable, easy to perform, non-
invasive test to detect cases, before substantial ocular morbidity has already 
occurred. Newer strategies need to be evolved to increase the efficiency and 
effectiveness of risk and disease identification in these patients. The good thing 
about glaucoma is that, if the disease is identified early enough, and the 
pathological process halted, or even slowed down, the patient’s sight can be 
saved to give him or her functional vision for the rest of their lives. Hence, the 
need for a reliable, non-invasive, investigative modality, which detects the 
disease early, cannot be overemphasized. 
 
 Optical coherence tomography is a new imaging modality, which has 
completely changed the way Ophthalmologists are approaching ocular disease. 
Previously, slit-lamps and bio-microscopy techniques empowered the 
ophthalmologist to directly visualize intraocular pathologies; examination of the 
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ocular fundus and the optic nerve head, with its size, shape, cupping, etc., was 
possible in a way, not seen in any other sub-specialty of medicine. But, Optical 
coherence tomography (OCT) imaging has taken this even further, and has 
made it possible for us to not only visualize all the above said structures, but 
also view deeper structures in cross-sections, like a histo-pathological section. 
The newer generation OCT machines use the swept source technology and 
produce clearer images with increased resolution and faster scanning speeds. 
OCT Angiography is a relatively newer technique that works using swept 
source technology, to generate volumetric angiography images, by detecting 
motion contrast. It can generate images delineating individual vascular plexus at 
different levels, providing information about the vascular perfusion at each 
layer of the retina.  
 
According to the vascular theory of pathogenesis of glaucoma, a vascular 
dysregulation, leading to changes in the retinal microcirculation, is responsible 
for the derangement of perfusion to the optic nerve head and peri-papillary 
retina. (36-47). But, there is also the concept that retinal ganglion cell loss is the 
precursor to reduction in vessel caliber and density in the retinal 
microcirculation, because of the reduced metabolic demand leading to 
vasoconstriction. This is in agreement with the observation of retinal arterial 
narrowing in patients with non-glaucomatous optic atrophy (46, 49, 50, 62-64). 
Therefore, in the case of glaucoma, the golden question that begs to be asked is 
‘Which came first; the chicken or the egg? The retinal ganglion cell loss or the 
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reduction in vessel density?’. In our quest for this answer, several studies have 
been conducted to analyze the retinal vascular bed, using various non-invasive 
and invasive techniques. The earlier studies tried using fluorescein angiography 
(FA) to study optic nerve head blood flow. (69, 70). But FA cannot be used on a 
regular basis to monitor patients for glaucoma because it is invasive and has its 
own side effects. Plus, there are also problems in accurate quantification of the 
deficit. Laser Doppler flowmetry and Laser speckle flowmetry are non-invasive 
techniques that have also been used to measure optic nerve head blood supply 
and they have demonstrated that there is significant reduction in the blood flow 
at the ONH in glaucomatous eyes (38, 47, 71). 
 
Despite all the information available, we are yet to quantify the retinal 
micro vascular network density, by a technique which is non-invasive, accurate 
and easily reproducible. This is where OCT Angiography really shines through, 
by providing cross sectional images, with an accurate wire frame of the entire 
micro vascular network at each level. 
 
 The purpose of this study was to explore the use of OCT Angiography in 
Glaucoma, by using the TRITON swept source OCT in the Indian population. 
The use of OCT angiography in Glaucoma has not yet been fully evaluated and 
its use to study vessel density to diagnose glaucoma, and to differentiate it from 
that of glaucoma suspects has not been quantified. We conducted this study to 
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define parameters and cut-offs, to differentiate glaucoma cases from suspects 
and normal patients, in the Indian population. 
 
  In our study, we recruited patients under three arms, early primary 
open angle glaucoma (POAG) patients, ocular hypertensives and normal 
controls. We chose early POAG patients as we believe that ocular hypertensives 
may be part of a spectrum of disease, which ranges from normals at one end to 
early POAG, and beyond, at the other end.  
 
There was no statistically significant difference in the sex or eye ratio 
between the three groups. But, even though there was no statistically significant 
difference in the age distribution among the participants (p = 0.067), we found 
that the patients belonging to the POAG group were in general, slightly older 
(Age ranging from 42 to 70 years). This is in agreement with several previous 
studies, which have found glaucoma to occur in a slightly older population (19, 
72, 73). 
 
As vascular perfusion to the optic nerve head depends on mean ocular 
perfusion pressure (MOPP), which is in turn a derivative of systemic blood 
pressure and intraocular pressure (74), we compared the MOPP of the patients 
between the three groups and we found that there was a statistically significant 
reduction in the MOPP from Normals to O-HTN group (p = <0.01) and POAG 
group. (p = <0.01). This is consistent with another study, which found a similar 
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trend in the MOPP between open angle glaucoma patients and normal controls. 
(75). 
 
 The Intraocular pressure (IOP) was measured at the time of evaluation of 
the patient and was compared between the three groups. In our sample groups, 
the difference between mean IOP in the O-HTN group and Normals was 
statistically significant (p = <0.01); and the difference between the mean IOP in 
the POAG group and Normals was also statistically significant (p<0.01). But 
the difference in mean IOP between the O-HTN group and POAG group was 
not significant statistically (p=0.947). One observation we found in our patients 
was that the O-HTN group had a slightly higher mean IOP than the POAG 
group. This is probably due to the fact that most of the patients recruited under 
the POAG group were already using Anti-glaucoma medications at the time of 
evaluation (94.12%) as compared to the O-HTN Group, which had fewer 
participants on IOP lowering medications at the time of examination (16.67%). 
 
 Vision assessment showed that patients of O-HTN and POAG have 
slightly worse visual acuity than the corresponding normals. The difference 
between mean BCVA in the O-HTN group and Normals was statistically 
significant (p = <0.01); and the difference between the mean BCVA in the 
POAG group and Normals was also statistically significant (p = <0.01). But the 
difference in mean BCVA between the O-HTN group and POAG group was not 
significant statistically (p = 1.00). This observation shows that, on close 
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evaluation, subtle changes in vision do exist, even in earlier stages of the 
disease. (Table 11) 
 
 On clinical evaluation of the optic nerve head, one striking feature that 
always gives us a clue to suspecting glaucoma is the cup to disc ratio (CDR). In 
our study, we found larger CDR in patients under the POAG group (Mean CDR 
0.74), as compared to the normals (Mean CDR 0.35) and O-HTN group (Mean 
CDR 0.39). We found a statistically significant difference in the CDR between 
the Normals and POAG group (p = <0.01), and also between the O-HTN Group 
and POAG group (p = <0.01), but no statistically significant difference in the 
CDR between Normals and O-HTN Group. (p = 0.754). This is consistent with 
findings in another study where larger CDR’s were associated with 
development of POAG and higher the CDR, more chance of the patient having 
POAG. (76). 
 
 The functional assessment of ganglion cell damage by visual field testing 
was done and machine calculated Global indices, i.e., the Mean Deviation and 
Pattern standard deviation were analyzed in each group. We found that there 
was a significant difference in the Visual Field Mean Deviation (MD) and 
Pattern Standard Deviation (PSD) between the Normals and POAG group (p = 
<0.01) and also a statistically significant difference between the O-HTN Group 
and POAG group (p = <0.01). But there was no statistically significant 
difference in the Visual Field Mean Deviation (MD) between Normals and O-
80	
	
HTN Group. (p = 1.00). This is consistent with the fact that in the O-HTN 
group, the field changes have not yet started to manifest, which makes the 
indices comparable to that of normal patients, whereas the early POAG patients 
show significantly worse indices. 
 
 Next, we evaluated the optic nerve head and retinal nerve fiber layer 
(RNFL) thickness by using swept source optical coherence tomography (DRI-
TRITON Plus). The DRI TRITON Plus is a multimodal imaging system. The 
same system can be used to capture fundus photos, with the area of interest set 
as the optic nerve head, for documentation and further follow up comparisons. 
It takes over 1,00,000 A scans/ second, which helps by producing clearer, 
crisper images of high resolution. This gave us information about the structural 
differences in the retinal nerve fiber thickness in the three groups. As the 
distribution of RNFL loss takes place in a segmental manner, we took into 
consideration the mean RNFL thickness as well as, subdividing the area as 
superior and inferior quadrants. We found that there was a significant difference 
in the Mean RNFL Thickness between the Normals and POAG group (p = 
<0.01) and also a significant difference between the O-HTN Group and POAG 
group (p = <0.01). In the Normals and O-HTN group, we found that the inferior 
RNFL thickness was greater than the superior quadrant, both being within the 
normal range for age of the patients, as also seen in another study done in the 
Indian population (77). Whereas, the reduction in the RNFL thickness seen in 
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the POAG group was consistent with RNFL loss following the ISNT rule, with 
inferior quadrant being more thinned than the superior quadrant. 
 
 One important finding in our study was that there was statistically 
significant difference in the Inferior RNFL Thickness between the Normals and 
O-HTN Group. (p = 0.020). From this, we postulate that, even though, in both, 
the Normals group and the O-HTN group, the Mean RNFL thickness is within 
the normal range for the population, there is still a significant reduction in the 
Inferior RNFL thickness in Ocular hypertensives, which may go un-noticed if 
the RNFL thickness data were to be assessed in isolation, without comparison. 
This has led us to believe that, in Ocular Hypertensives, even though the RNFL 
thickness is within normal range for the population (towards the lower end of 
normal), the thinning has already started, prior to detection. 
 
 Next, using the DRI-TRITON Plus, we captured OCT Angiography 
images of a 3 x 3 mm area, centered around the optic nerve head, and using 
custom grading software of the device, generated maps, to produce two-
dimensional images by collapsing the micro vascular frameworks, of all the 
layers from the internal limiting membrane to the retinal pigment epithelium.  
This is one of the biggest advantages of OCT Angiography; to delineate the 
retinal micro vascular network at each and every level, in great detail. These 
images were edited and analyzed for each of the areas of interest (Optic nerve 
head, peri-papillary area, whole papillary area, superior quadrant and inferior 
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quadrant of the papillary area), to calculate the vessel density (in area 
percentage). 
 
 We compared the images and data from the three groups; normals, O-
HTN, and early POAG group, to search for any significant differences, by 
performing paired analysis between the groups, for each of the specific areas of 
interest. Previously, various researchers have tried to analyze the Vessel 
densities in Normals Vs. POAG patients; Normals Vs. Glaucoma suspects Vs. 
POAG patients; and even divided the POAG patients into mild, moderate and 
severe groups. (57, 64, 65, 78 – 81). All these studies have used OCT 
angiography images of different area measurements, and either machine inbuilt 
analysis protocols or used external third party software applications, by 
different techniques, to analyze the images. Therefore, on review of these 
studies, we have found that absolute values of the vessel densities, when 
compared between the studies may vary depending on the technique used to 
analyze the OCT angiography vascular maps. But, one fact that was evident, is 
that there was a definite trend or pattern in the distribution of the vessel 
densities in the different populations, i.e., the vessel densities (Vd) were highest 
in the normals, and mildly reduced in the suspects (Ocular hypertensives) and 
were considerably reduced in the diseased (POAG) group. 
 
In our study, firstly, we compared the vessel densities at the optic nerve 
head (VdONH) between the Normals, O-HTN group and POAG group; 
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measurements, in the descending order of percentage area of Vascular density, 
were, Normals > O-HTN > POAG Group (in that order) and the difference was 
statistically significant between all three groups. (p<0.01) 
This was in agreement with other previous studies (57, 64, 65, 78 – 81). All the 
other areas of interest were also analyzed and there was a statistically 
significant difference in the vessel densities between the three groups, following 
the same trend. The normals had the highest densities, followed by the suspects 
(ocular hypertensives) and lastly the POAG patients, showing the least 
densities. This was also in agreement with the previous similar studies. (57, 64, 
65, 78 – 81). 
 
 In a few studies, (57, 78), the machine itself comes with inbuilt image 
analysis protocols and software, which provides a vessel density measurement 
directly. This may be more accurate in measurements. In our study we were 
partly limited by the fact that the machine did not have software protocols to 
directly measure the vessel density, and the images had to be exported out of 
the machine and analyzed separately to deduce the vessel density. This manual 
method may give rise to few errors, but in order to overcome the same, we 
performed the measurements on the same site of interest, twice, separately and 
took the average of the two, before utilizing the data for analysis. This, we 
believe, may to some extent, minimize the errors involved. 
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In order to test the accuracy of each of the parameters to differentiate 
between normals, suspects (ocular hypertensives), and disease (POAG patients), 
we plotted the observations in each of the groups, for each area of interest, and 
by comparing the sensitivity and specificity at each point; we calculated a cut-
off value for each of the parameters, by plotting Receiver Operating 
Characteristic (ROC) Curves. To differentiate O-HTN patients from normals, 
we found that the Peri-Papillary area (VdPPA), Papillary area (VdPA) and 
Inferior Papillary area (VdIPA) Vascular density measurements had the highest 
accuracy (AUC = 1.000), followed by Optic Nerve Head area (VdONH) (AUC 
= 0.9854) and Superior Papillary area (VdSPA) Vascular Density measurements 
(AUC = 0.9825). This is in agreement with the work done previously, by other 
researchers, who have found that, when the whole image or large area of the 
image is taken into account for measurement, as in the case of the papillary area 
being considered, there is a higher probability of including more of the 
vasculature and hence the differences are more apparent. (57) 
 
Next, we compared the data in O-HTN group to early POAG group, and 
this also showed a similar trend. The Peri-Papillary area (VdPPA) (AUC = 
0.9967), Inferior Papillary area (VdIPA) (AUC = 0.9967) and Papillary area 
(VdPA) (AUC = 0.9837) Vascular density measurements had the highest 
accuracy to differentiate between the two groups, and were found to be better 
than Superior Papillary area (VdSPA) (AUC = 0.9444) and Optic Nerve Head 
area (VdONH) (AUC = 0.9052) Vascular Density measurements. 
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Therefore, in our study, papillary and peri-papillary vessel density 
measurements have been found to have the highest accuracy in differentiating 
Normals, O-HTN patients and early POAG patients. Similar results have also 
been encountered in a few other studies (57, 64, 81) whereas the AUC values in 
some other studies for the same area of interest were slightly lower than our 
own values. (80). Few other studies have also shown that in addition to the 
papillary area, the superior papillary area vessel density also has a high 
accuracy to differentiate normals and O-HTN group. (65). 
 
The reason for such a degree of variability in the results between the 
different studies may be the use of different machines to capture the images, the 
different protocols and image analysis techniques (machine in built or external 
third party). But finally, the majority of the studies done so far, including our 
own, concur that the papillary area vascular density and peri-papillary vessel 
density area measurements have the highest accuracy and diagnostic ability to 
classify a patient into normal, suspect (ocular hypertensive) or disease (POAG) 
group. 
 
Our study population included patients who were known diabetics and 
hypertensives, diseases that are known to cause changes in the microvasculature 
throughout he body. Even though we have already excluded patients who have 
any form of retinopathy, we still wanted to assess whether our results would be 
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grossly different if we perform our analysis after excluding the diabetics and 
hypertensives. On doing so, and comparing our results from the previous data 
set (diabetics and hypertensives included) and the fresh data set (after excluding 
the diabetics and hypertensives), we found that there wasn’t much difference 
between the two. Therefore, we concluded, it is likely that, in our group of 
patients, diabetes and hypertension did not have a significant effect on the 
retinal vasculature and could be ignored as a potential confounding factor in 
analysis and conclusions. 
 
We also analyzed the correlation between the RNFL thickness and vessel 
density changes and we found that a lower RNFL Thickness was associated 
with a lower overall mean vessel density (papillary area vessel density). This 
was also correlating with the worsening of the global indices on automated 
perimetry, which was our yardstick in assessing functional deterioration. 
 
Thus, at the end of our discussion, we come back to the question that set 
us out on this quest for truth; Which comes first, the RNFL thinning or the 
reduction in vascular density?  In our study, in view of the analysis being cross-
sectional by design, even through we were able to establish a significant link 
between RNFL loss and reduced vessel density, we are unable to establish a 
temporal cause-effect relationship of one to the other. This, though a limitation 
of our study, has given an idea about the prospects of future research. 
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In further studies, if one is able to follow up suspects, or even patients 
with risk factors for development of glaucoma, with serial vessel density 
measurements and RNFL thickness OCT scans or absolute retinal ganglion cell 
counts, and if this data is plotted against time, we may be able to establish a 
temporal relationship between the two. This may provide us with new 
information, which may improve our understanding of the disease and its 
pathogenesis and provide us with new treatment strategies, which will 
strengthen our armamentarium in this fight against the silent thief of sight that 
is glaucoma. 
 
NORMAL 
 
OCULAR 
HYPERTENSION 
 
EARLY PRIMARY 
OPEN ANGLE 
GLAUCOMA 
 
   
   
Colour Plate 22: Optic Disc photo and corresponding OCT-A image (Sample Image) 
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LIMITATIONS 
 
• Cross-sectional study; therefore will not be able to assess for cause- 
effect relationship between vessel density and RNFL thinning. 
• Vision was recorded in Snellen’s format and had to be converted into 
LogMar for calculations. 
• The patients in the Disease (POAG) group, even though statistically age 
matched, were slightly older than the patients in the normals group and 
O-HTN group 
• Motion artifacts due to blinking or eye movement during image 
acquisition, caused a problem by producing poor quality images and the 
images had to be captured multiple times to get good quality images. 
 
 
 
 
 
 
 
 
 
 
 
89	
	
CONCLUSIONS 
Using the DRI-TRITON Plus swept source optical coherence 
tomography machine, we can acquire high resolution OCT scans which provide 
information about, not only the retinal nerve fiber layer thickness, but also 
about the vessel density in the retinal microcirculation in all the layers of the 
retina. Our study shows that there is a significant relationship between the 
vessel density and the structural changes in the retina in glaucoma, in the form 
of RNFL thinning and functional changes in glaucoma, in the form of 
worsening Global indices on automated perimetry. We found that the Inferior 
RNFL thickness in the Ocular hypertension group, even though within normal 
limits, for age, was at the lower end of normal, and that there was a statistically 
significant difference between the normals and suspects (O-HTN group), which 
may be missed if only RNFL thickness is seen in isolation. We also found that 
papillary area and peri–papillary area vessel densities had the best diagnostic 
ability and accuracy to correctly differentiae the normals, suspects (O-HTN) 
and diseased (early POAG) groups, which were in agreement with other 
previous studies. Even though a significant relationship exists between RNFL 
loss and decrease in vessel density, further longitudinal studies are needed to 
establish a temporal cause-effect relationship between the two entities. 
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ANNEXURE 
 
1) PROFORMA 
 
Study title: ANALYSIS OF RETINAL VASCULAR DENSITY USING OPTICAL 
COHERENCE TOMOGRAPHY ANGIOGRAPHY, TO DIFFERENTIATE 
HEALTHY, GLAUCOMA SUSPECT AND GLAUCOMATOUS EYES. 
 
DATE: - 
 
1. DEMOGRAPHICS 
   
SERIAL NO: - 
 
NAME                                                                            HOSPITAL NO: - 
 
AGE: - 
 
SEX: - MALE / FEMALE 
 
 
PHONE NO: - 
 
ADDRESS: - 
 
 
 
2.CLINICAL EVALUATION - HISTORY 
 
OCULAR COMPLAINTS: - 
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PAST HISTORY  (ANY OCULAR SURGERIES/ TREATMENT) 
 
 
 
 
 
SYSTEMIC HISTORY 
 
DM (YES / NO); If yes, duration 
 
HTN (YES / NO); If yes, duration 
 
IHD (YES / NO); If yes, duration 
 
BRONCHIAL ASTHMA (YES / NO); If yes, duration                  
 
 
MEDICATION HISTORY (INCLUDING ANTI-GLAUCOMA MEDICATIONS) 
 
 
 
 
ANTIGLAUCOMA MEDICATIONS: 
Number of medications: - 
Duration of use: - 
 
 
 
3.CLINICAL EVALUATION - EXAMINATION 
BLOOD PRESSURE (In millimeters of mercury): - 
 
OCULAR PERFUSION PRESSURE (In millimetetrs of mercury): - 
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OCULAR EXAMINATION 
OCULAR EXAMINATION 
 
RIGHT EYE 
 
LEFT EYE 
 
VISION 
Unaided / Best Corrected 
Visual  
Acuity) 
UNAIDED UNAIDED 
BCVA BCVA 
ANTERIOR SEGMENT  
EXAMINATION 
 
  
 RIGHT EYE 
 
LEFT EYE 
 
IOP (In mm Hg) 
 
  
GONIOSCOPY 
(RP center grading) 
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FUNDUS EXAMINATION 
 
RIGHT EYE 
 
LEFT EYE 
DISC 
COLOUR 
SIZE 
SHAPE 
MARGINS 
  
VERTICAL DISC DIAMETER ( in mm) 
 
  
CUP: DISC RATIO 
 
  
ARTERY: VEIN RATIO 
 
  
MACULA 
 
  
FOVEAL REFLEX 
 
  
 
4.INVESTATIGATIONS 
I) CENTRAL CORNEAL THICKNESS 
(In micrometers) 
RIGHT EYE 
 
LEFT EYE 
  
 
 
II) VISUAL FIELD TESTING BY HFA RIGHT EYE 
 
LEFT EYE 
FIELD DEFECTS (IF ANY) 
 
  
MEAN DEVIATION (dB) 
 
  
PATTERN STANDARD DEVIATION 
(dB) 
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III) OCT RNFL THICKNESS RIGHT EYE 
 
LEFT EYE 
MEAN RNFL THICKNESS (in 
micrometres) 
 
  
SUPERIOR RNFL THICKNESS (in 
micrometres) 
 
  
INFERIOR RNFL THICKNESS (in 
micrometres) 
 
  
 
 
IV) OCT ANGIOGRAPHY VESSEL 
DENSITY 
(IN PERCENTAGE) 
 
RIGHT EYE 
 
LEFT EYE 
OPTIC NERVE HEAD (%)   
PERIPAPILLARY AREA (%) 
 
  
PAPILLARY AREA (%) 
 
  
SUPERIOR PAPILLARY AREA (%) 
 
 
  
INFERIOR PAPILLARY AREA (%) 
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2) PATIENT INFORMATION (English) 
 
Study title: ANALYSIS OF RETINAL VASCULAR DENSITY USING OPTICAL 
COHERENCE TOMOGRAPHY ANGIOGRAPHY, TO DIFFERENTIATE HEALTHY, 
GLAUCOMA SUSPECT AND GLAUCOMATOUS EYES. 
 
 
You are being invited to take part in this research study carried out in the Department of 
Ophthalmology, Schell Eye Hospital, Christian Medical College, Vellore. The information in 
this document is meant to help you decide whether or not to take part in this study.  
Before you decide whether or not you wish to take part, you should read the information 
provided below carefully and, if you wish, discuss it with your relatives.  Take time to ask 
questions – do not feel rushed or under pressure to make a quick decision. 
You should clearly understand the risks and benefits of taking part in this study so that 
you can make a decision that is right for you. This process is known as ‘Informed Consent’.  
You do not have to take part in this study and a decision not to take part will not effect on 
your future medical care.  
You can change your mind about taking part in the study any time you like.  Even if the 
study has started, you can still opt out.  You do not have to give us a reason.  If you do opt 
out, it will not affect the quality of treatment you get in the future.  
 
 
What is the purpose of the study? 
Our study will assess the differences in microscopic circulation in the retina (the nerve of 
the eye), using a non-invasive investigative test, Optical coherence tomography angiography, 
between glaucoma suspects, and age matched normals (controls) and diagnosed early 
glaucoma patients. This angiography test is done with a machine, which takes pictures of the 
retina from outside (without any dye of injection being required to be given from outside). It 
is a painless and completely risk free test. 
 
The volunteers with also be undergoing the routine, full eye examination and also the 
following additional tests, all of which are completely, non-invasive: - 
• Central corneal thickness measurement 
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• Visual field testing with Automated visual field analyzer 
• Retinal nerve fiber layer measurement, with Swept source OCT. 
All these are routinely used tests in the evaluation of glaucoma. 
 
Why have I been invited? 
You have been chosen because you have fit one of the following criteria: - 
• You are either a patient who has examination findings suspicious of glaucoma. 
• Or, you are either a diagnosed patient of early glaucoma 
• Or, you are chosen as a healthy volunteer, to be included in the control group. 
 
What will happen if i take part? 
If you take part in the study, you will be requested to provide the required clinical 
information and then undergo the routine eye examination and the required clinical 
investigations, which are non-invasive. 
 
Expenses and payments? 
There are no additional expenses or payments. 
 
What are the possible benefits of taking part? 
If you are a glaucoma suspect, then, the tests needed as part of evaluation, will be done 
free of cost, and if the results point towards glaucoma, then, we can plan for further 
management. 
 
If you are already a diagnosed glaucoma patient, then, the clinical testing and 
investigations will be part of the regular follow up care. No additional investigations, other 
than those needed for routine follow up care, will be performed, and no extra cost will be 
levied on you. Additionally, by participating in this study, you will be helping future patients 
by helping to advance our understanding of the disease, which currently ails many others like 
yourself. 
 
If you are a normal patient, recruited as a control, then you will be helping future patients, 
for whom newer treatment strategies may be developed as a result of better understanding of 
this disease. 
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What are the possible risks of taking part? 
There are no risks involved in taking part in this study. All the examination procedures 
and investigations to be done are completely non-invasive and pain free. 
 
Will my taking part be kept confidential? 
All patient information is stored on password protected computer databases and in locked 
filing cabinets and will only be accessible to the research team. 
 
What if there is a problem? 
If you wish to complaint about any aspect of the way in which you have been approached 
or treated during the course of this study, you should contact the Principal investigator or you 
may contact Research Office, Carman Block, Bagayam, Vellore, 632002, email - 
research@cmcvellore.ac.in or researchothers@cmcvellore.ac.in, phone - 0416 2284294. 
 
What will happen to any of my test results/samples I give? 
The test results will be kept safe in the hospital’s patient information databases, which are 
password protected and accessible to only the members of the research team, who are 
medical professionals. 
 
How will the information I provide be used? 
We plan to analyze the information collected and understand the disease condition, that is, 
glaucoma, in a better way. We will then publish the results in a health journal so others can 
read about it and learn from the results of the study, so that the new found information may 
be used to benefit others, the world over. The personal information collected will still remain 
strictly confidential, and only the interpretations of the data will be published. 
 
Who has reviewed this study? 
The Institutional Review Board (IRB) of the Christian Medical College, Vellore, has 
reviewed this study.  
 
 
 
You have the right to confidentiality regarding the privacy of your medical information 
(personal details, results of physical examinations, investigations, and your medical 
107	
	
history). By signing this document, you will be allowing the research team investigators, if 
required to access your medical information.   
                         
The results of clinical tests and therapy performed as part of this research may be 
included in your medical record. The information from this study, if published in scientific 
journals or presented at scientific meetings, will not reveal your identity.  
Thank you for reading this. 
If you agree to enter the study, please sign the attached consent form. 
   
Contact Person (Principal Investigator) 
Dr. Bharath Kumar. K 
Department of Ophthalmology, Schell Campus, 
Christian Medical College, Vellore. 
Phone: 09600590205, email: bharathk1989two@gmail.com 
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3) INFORMED CONSENT FORM FOR SUBJECTS (English) 
 
Study title: ANALYSIS OF RETINAL VASCULAR DENSITY USING OPTICAL 
COHERENCE TOMOGRAPHY ANGIOGRAPHY, TO DIFFERENTIATE HEALTHY, 
GLAUCOMA SUSPECT AND GLAUCOMATOUS EYES. 
 
  
Study Number: ____________ 
 
Subject’s Name: _________________________________________ 
 
Date of Birth / Age: ___________________________ 
 
(Subject) 
 
(i)  I confirm that I have read and understood the information sheet dated 
____________ for the above study and have had the opportunity to ask questions. [  ] 
 
(ii)  I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal rights 
being affected. [  ] 
 
(iii)  I understand that, the Ethics Committee and the regulatory authorities will not 
need my permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the trial. I 
agree to this access. However, I understand that my identity will not be revealed in any 
information released to third parties or published. [  ] 
 
(iv)  I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). [  ] 
 
 
(v)  I agree to take part in the above study. [  ] 
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Signature (or Thumb impression) of the Subject/Legally Acceptable  
 
Date: _____/_____/______ 
 
 
Signatory’s Name: _________________________________ Signature:  
 
Or 
 
 
 
 
 
 
 
Representative: _________________ 
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________ 
 
 
Signature of the Investigator &Name: ________________________ 
 
Date: _____/_____/______ 
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4) PATIENT INFORMATION (Tamil) 
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5) INFORMED CONSENT FORM FOR SUBJECTS (Tamil) 
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6) INSTITUTIONAL REVIEW BOARD APPROVAL 
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7) DATA SHEET LEGEND 
GROUP 1 – CONTROLS 
2 – OCULAL HYPERTENSION 
3 – PRIMARY OPEN ANGLE GLAUCOMA 
EYE 1 – RIGHT 
2 - LEFT 
SEX 1 – MALE 
2 - FEMALE 
DM 1 – PRESENT 
2 - ABSENT 
HTN 1 – PRESENT 
2 - ABSENT 
IHD 1 – PRESENT 
2 - ABSENT 
BRONCHIAL ASTHMA 1 – PRESENT 
2 - ABSENT 
AGM(ANTI-GLAUCOMA 
MEDICATIONS) 
1 – YES 
2 - NO 
CATARACT 1 – PRESENT 
2 – ABSENT 
3 - IOL 
RAPD 1 – PRESENT 
2 - ABSENT 
GONIOSCOPY 0 – NO DIPPING 
1 – DIPPING PRESENT 
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2 – SCHWALBE’S LINE AND ANT 1/3rd OF TRAB MESHWORK 
SEEN 
3 – MID 1/3RD OF TRAB MESHWORK 
4 – POST 1/3RD OF TRAB MESHWORK 
5 – SCLERAL SPUR 
6 – CILIARY BODY BAND SEEN 
DISC 1 – COLOUR, SIZE, SHAPE, MARGINS NORMAL 
2 - COLOUR, SIZE, SHAPE, MARGINS ABNORMAL 
 
 
 
 
 
MOPP MEAN OCULAR PERFUSION PRESSURE (mm hg) 
BCVA BEST CORRECTED VISUAL ACUITY 
RAPD RELATIVE AFFERENT PUPILLARY DEFECT 
IOP INTRAOCULAR PRESSURE (mm hg) 
VDD VERTICAL DISC DIAMETER (millimeters) 
CDR CUP DISC RATIO 
CCT  CENTRAL CORNEAL THICKNESS (micrometers) 
MD MEAN DEVIATION (decibels) 
PSD PATTERN STANDARD DEVIATION (decibels) 
MRNFL MEAN RETINAL NERVE FIBRE LAYER THICKNESS (micrometers) 
SRNFL SUPERIOR RETINAL NERVE FIBRE LAYER THICKNESS 
(micrometers) 
IRNFL INFERIOR RETINAL NERVE FIBRE LAYER THICKNESS 
(micrometers) 
VdONH VESSEL DENSITY – OPTIC NERVE HEAD (%) 
VdPPA VESSEL DENSITY – PERIPAPILLARY AREA (%) 
VdPA VESSEL DENSITY – PAPILLARY AREA (%) 
VdSPA VESSEL DENSITY – SUPERIOR PAPILLARY AREA (%) 
VdIPA VESSEL DENSITY – INFERIOR PAPILLARY AREA (%) 
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8) DATA SPREADSHEET 
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9) SNELLEN VISUAL ACUITY TO LOGMAR VISUAL ACUITY 
CONVERSION TABLE 
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